Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Schizophr Res

Retrieve available abstracts of 706 articles:
HTML format

Single Articles

    June 2022
  1. BEGUE I, Brakowski J, Seifritz E, Dagher A, et al
    Cerebellar and cortico-striatal-midbrain contributions to reward-cognition processes and apathy within the psychosis continuum.
    Schizophr Res. 2022;246:85-94.
    PubMed     Abstract available

  2. RAUCHER-CHENE D, Pochiet G, Lavigne KM, Heinrichs RW, et al
    Normal-range verbal memory in the first-episode of psychosis: Clinical and functional outcomes across 24 months and impact of estimated verbal memory decrement.
    Schizophr Res. 2022;246:75-84.
    PubMed     Abstract available

  3. NIZNIKIEWICZ MA, Brady RO, Whitfield-Gabrieli S, Keshavan MS, et al
    Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis.
    Schizophr Res. 2022;246:60-62.

  4. MORKVED N, Johnsen E, Kroken RA, Winje D, et al
    Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial.
    Schizophr Res. 2022;246:49-59.
    PubMed     Abstract available

  5. KUO SS, Musket CW, Rupert PE, Almasy L, et al
    Age-dependent patterns of schizophrenia genetic risk affect cognition.
    Schizophr Res. 2022;246:39-48.
    PubMed     Abstract available

    Mathematical nosology: Computational approaches to understanding psychosis.
    Schizophr Res. 2022 Jun 10. pii: S0920-9964(22)00202.

  7. SCHOFIELD P, Thisted Horsdal H, Das-Munshi J, Thygesen M, et al
    A comparison of neighbourhood level variation and risk factors for affective versus non-affective psychosis.
    Schizophr Res. 2022 Jun 10. pii: S0920-9964(22)00192.
    PubMed     Abstract available

  8. CATALANO LT, Wynn JK, Green MF, Gold JM, et al
    Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study.
    Schizophr Res. 2022;246:7-16.
    PubMed     Abstract available

  9. GALIANO RUS S, Ortiz Garcia de la Foz V, Arias-Loste MT, Iruzubieta P, et al
    Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study.
    Schizophr Res. 2022;246:30-38.
    PubMed     Abstract available

  10. LALLY J, Ajnakina O, Stubbs B, Gardner-Sood P, et al
    Vitamin D and cardiometabolic outcomes in first episode psychosis (FEP): A prospective cohort study.
    Schizophr Res. 2022;246:26-29.

  11. SCHOR SH, Gibbs JS, Gouse BM, Brown HE, et al
    A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts.
    Schizophr Res. 2022;246:63-64.

  12. ORTIZ BB, Gadelha A, Bressan RA
    Should we rethink how we introduce schizophrenia?
    Schizophr Res. 2022;244:134.

  13. PHELAN S, Sigala N
    The effect of treatment on insight in psychotic disorders - A systematic review and meta-analysis.
    Schizophr Res. 2022;244:126-133.
    PubMed     Abstract available

    May 2022
  14. SEGURA AG, Martinez-Pinteno A, Gasso P, Rodriguez N, et al
    Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort.
    Schizophr Res. 2022;244:101-110.
    PubMed     Abstract available

  15. LIANG L, Heinrichs RW, Liddle PF, Jeon P, et al
    Cortical impoverishment in a stable subgroup of schizophrenia: Validation across various stages of psychosis.
    Schizophr Res. 2022 May 26. pii: S0920-9964(22)00188.
    PubMed     Abstract available

  16. PALOMAR-CIRIA N, Cegla-Schvartzman F, Bello HJ, Martinez-Ales G, et al
    Diagnostic stability of schizophrenia in clinical settings: An observational study of 198,289 patient/years.
    Schizophr Res. 2022;244:81-83.

  17. SETIEN-SUERO E, Ayesa-Arriola R, Pena J, Crespo-Facorro B, et al
    Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosis.
    Schizophr Res. 2022;244:71-80.
    PubMed     Abstract available

  18. KURTZ MM
    Kraepelin, schizophrenia and the first biological era in psychiatry.
    Schizophr Res. 2022;244:69-70.

  19. WILLIAMS TF, Powers AR, Ellman LM, Corlett PR, et al
    Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis.
    Schizophr Res. 2022;244:58-65.
    PubMed     Abstract available

  20. SCHIFFMAN J, Horton LE, Landa Y, Woods SW, et al
    Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.
    Schizophr Res. 2022;244:55-57.

  21. SANCHEZ-TORRES AM, Peralta V, Gil-Berrozpe GJ, Mezquida G, et al
    The network structure of cognitive deficits in first episode psychosis patients.
    Schizophr Res. 2022;244:46-54.
    PubMed     Abstract available

  22. ALONSO-SANCHEZ MF, Limongi R, Gati J, Palaniyappan L, et al
    Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach.
    Schizophr Res. 2022 May 11. pii: S0920-9964(22)00160.
    PubMed     Abstract available

  23. CARRA G, Crocamo C, Bartoli F, Angermeyer M, et al
    Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: A longitudinal analysis from the EuroSc study.
    Schizophr Res. 2022;244:21-28.
    PubMed     Abstract available

    Commentary on whether progressive brain change underlies the pathology of schizophrenia: Should this even be debated?
    Schizophr Res. 2022;244:18-20.

  25. CAVALIERE VS, Glassman M, DiPaula BA, Mackowick M, et al
    Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness.
    Schizophr Res. 2022;243:163-169.
    PubMed     Abstract available

  26. STEPHANE M, Dzemidzic M, Yoon G
    Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study.
    Schizophr Res. 2022;243:475-480.
    PubMed     Abstract available

  27. NARITA Z, Koyanagi A, Oh H, DeVylder J, et al
    Association between incarceration and psychotic experiences in a general population sample.
    Schizophr Res. 2022;243:112-117.
    PubMed     Abstract available

  28. CEREDA G, Boscutti A, Lazzaretti M, Enrico P, et al
    Amitriptyline for clozapine-induced hypersalivation: A case series.
    Schizophr Res. 2022;243:110-111.

  29. JIMENO N, Gomez-Pilar J, Poza J, Hornero R, et al
    (Attenuated) hallucinations join basic symptoms in a transdiagnostic network cluster analysis.
    Schizophr Res. 2022;243:43-54.
    PubMed     Abstract available

  30. RUIZ DE PELLON-SANTAMARIA A, Sarasqueta-Eizaguirre C, Basterrechea-Pena FJ
    An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.
    Schizophr Res. 2022;243:486-488.

  31. ZHANG L, Zhang R, Han S, Womer FY, et al
    Three major psychiatric disorders share specific dynamic alterations of intrinsic brain activity.
    Schizophr Res. 2022;243:322-329.
    PubMed     Abstract available

  32. HJELSENG IV, Vaskinn A, Ueland T, Lunding SH, et al
    Childhood trauma is associated with poorer social functioning in severe mental disorders both during an active illness phase and in remission.
    Schizophr Res. 2022;243:241-246.
    PubMed     Abstract available

  33. JEREMIAN R, Bani-Fatemi A, Strauss JS, Tasmim S, et al
    Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt.
    Schizophr Res. 2022;243:222-224.

  34. TASMIM S, Bani-Fatemi A, Dada OD, Wang KZ, et al
    Recent health-related stressful life events predictive of emergent suicidal ideation in schizophrenia.
    Schizophr Res. 2022;243:220-221.

    April 2022
  35. MALHI GS, Bell E
    Reframing schizophrenia: Altering our perceptions?
    Schizophr Res. 2022;244:8-9.

  36. TAKAHASHI T, Wood SJ, Yung AR, Nelson B, et al
    Pineal morphology of the clinical high-risk state for psychosis and different psychotic disorders.
    Schizophr Res. 2022;244:1-7.
    PubMed     Abstract available

  37. HAINING K, Grent-'t-Jong T, Chetcuti B, Gajwani R, et al
    Computerised cognitive training during early-stage psychosis improves cognitive deficits and gamma-band oscillations: A pilot study.
    Schizophr Res. 2022;243:217-219.

  38. GAWDE U, Hegde P, Desai K, Barai RS, et al
    Multimorbidity landscape of schizophrenia: Insights from meta-analysis of genome wide association studies.
    Schizophr Res. 2022;243:214-216.

  39. WEINREB S, Li F, Kurtz MM
    A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter?
    Schizophr Res. 2022;243:206-213.
    PubMed     Abstract available

  40. MAMTANI H, Pathak H, Sakhardande KA, Gowda GS, et al
    Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?
    Schizophr Res. 2022;243:203-205.

  41. GUPTA T, Horton WS, Haase CM, Carol EE, et al
    Clues from caregiver emotional language usage highlight the link between putative social environment and the psychosis-risk syndrome.
    Schizophr Res. 2022 Apr 7. pii: S0920-9964(22)00151.
    PubMed     Abstract available

  42. AMSALEM D, Valeri L, Jankowski SE, Yang LH, et al
    Reducing public stigma toward individuals with psychosis across race and gender: A randomized controlled trial of young adults.
    Schizophr Res. 2022;243:195-202.
    PubMed     Abstract available

  43. SHAKIR M, Willems AE, van Harten PN, van Lutterveld R, et al
    The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic ra
    Schizophr Res. 2022;243:187-194.
    PubMed     Abstract available

    Editorial for Special Issue: From cytokines to climate and C-sections and from micronutrients to the microbiome: Neurodevelopment and the risk for psychosis.
    Schizophr Res. 2022 Apr 5. pii: S0920-9964(22)00077.

  45. MURRAY RM, Bora E, Modinos G, Vernon A, et al
    Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline.
    Schizophr Res. 2022;243:181-186.
    PubMed     Abstract available

  46. SARPAL DK, Blazer A, Wilson JD, Calabro FJ, et al
    Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia.
    Schizophr Res. 2022;243:170-177.
    PubMed     Abstract available

    March 2022
  47. STONE WS, Phillips MR, Yang LH, Kegeles LS, et al
    Neurodegenerative model of schizophrenia: Growing evidence to support a revisit.
    Schizophr Res. 2022;243:154-162.
    PubMed     Abstract available

  48. KHAU M, Tabbane K, Bloom D, Abadi S, et al
    Pragmatic implementation of the Clinical Global Impression Scale of Severity as a tool for measurement-based care in a first-episode psychosis program.
    Schizophr Res. 2022;243:147-153.
    PubMed     Abstract available

  49. TANG CH, Ramcharran D, Qiu H, Chung KH, et al
    Attaching importance to the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia.
    Schizophr Res. 2022 Mar 22. pii: S0920-9964(22)00129.

  50. SUHAS S, Mehta UM
    A redux of schizophrenia research in 2021.
    Schizophr Res. 2022 Mar 14. pii: S0920-9964(22)00130.

  51. ASKEVIS-LEHERPEUX F, Hazo JB, Agoub M, Baleige A, et al
    Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features.
    Schizophr Res. 2022 Mar 13. pii: S0920-9964(22)00119.

  52. SHARPE V, Schoot L, Lewandowski KE, Ongur D, et al
    We both say tomato: Intact lexical alignment in schizophrenia and bipolar disorder.
    Schizophr Res. 2022;243:138-146.
    PubMed     Abstract available

  53. LOPEZ-DIAZ A, Ayesa-Arriola R, Garrido-Torres N, Otiz-Garcia de la Foz V, et al
    A proxy measure of premorbid adjustment in psychosis for large-scale epidemiological studies and electronic health record-based research.
    Schizophr Res. 2022 Mar 11. pii: S0920-9964(22)00112.

  54. PENCE AY, Pries LK, Ferrara M, Rutten BPF, et al
    Gender differences in the association between environment and psychosis.
    Schizophr Res. 2022;243:120-137.
    PubMed     Abstract available

  55. COSTARDI CG, Malinowski F, Fonseca L, Redondo L, et al
    COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey.
    Schizophr Res. 2022 Mar 4. pii: S0920-9964(22)00118.

  56. YONEZAWA K, Tani H, Nakajima S, Nagai N, et al
    AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding.
    Schizophr Res. 2022;243:98-109.
    PubMed     Abstract available

  57. SAKS ER
    Holding onto the center: Lived experience and the construct of schizophrenia.
    Schizophr Res. 2022 Mar 2. pii: S0920-9964(22)00094.

  58. ALPHS L, Brown B, Turkoz I, Baker P, et al
    The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder.
    Schizophr Res. 2022;243:86-97.
    PubMed     Abstract available

  59. LUCKHOFF HK, Asmal L, Scheffler F, du Plessis S, et al
    Sex and gender associations with indicators of neurodevelopmental compromise in schizophrenia spectrum disorders.
    Schizophr Res. 2022;243:70-77.
    PubMed     Abstract available

  60. RANJAN T, Melcher J, Keshavan M, Smith M, et al
    Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study.
    Schizophr Res. 2022;243:64-69.
    PubMed     Abstract available

  61. MCGURK SR, Xie H, Bond GR, Mueser KT, et al
    Impact of cognitive remediation on the prediction of employment outcomes in severe mental illness.
    Schizophr Res. 2022;241:149-155.
    PubMed     Abstract available

  62. STEENKAMP L, Weijers J, Gerrmann J, Eurelings-Bontekoe E, et al
    The relationship between childhood abuse and severity of psychosis is mediated by loneliness: an experience sampling study.
    Schizophr Res. 2022;241:306-311.
    PubMed     Abstract available

    February 2022
  63. FIRST MB, Lieberman JA
    How should we diagnose schizophrenia: Don't throw the baby out with the bath water.
    Schizophr Res. 2022 Feb 28. pii: S0920-9964(22)00034.

  64. TANDON R, Keshavan M, Nasrallah H
    Reinventing schizophrenia. Updating the construct.
    Schizophr Res. 2022 Feb 28. pii: S0920-9964(22)00093.

    The construct of schizophrenia as a human-specific condition.
    Schizophr Res. 2022 Feb 28. pii: S0920-9964(22)00092.

  66. BIOQUE M, Mezquida G, Amoretti S, Garcia-Rizo C, et al
    Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia.
    Schizophr Res. 2022;243:32-42.
    PubMed     Abstract available

  67. PHAHLADIRA L, Asmal L, Luckhoff HK, du Plessis S, et al
    The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia.
    Schizophr Res. 2022;243:17-23.
    PubMed     Abstract available

  68. WANG Z, Fu Y, Jiang F, Chen L, et al
    Further evidence and meta-analysis support association of a single nucleotide polymorphism rs4765905 in CACNA1C with schizophrenia.
    Schizophr Res. 2022 Feb 24. pii: S0920-9964(22)00062.

  69. AKOURI-SHAN L, DeLuca JS, Pitts SC, Jay SY, et al
    Internalized stigma mediates the relation between psychosis-risk symptoms and subjective quality of life in a help-seeking sample.
    Schizophr Res. 2022;241:298-305.
    PubMed     Abstract available

  70. RASMUSSEN AR, Parnas J
    What is obsession? Differentiating obsessive-compulsive disorder and the schizophrenia spectrum.
    Schizophr Res. 2022;243:1-8.
    PubMed     Abstract available

  71. HUANG BJ, Pu CC, Miao Q, Ma K, et al
    Neurocognitive trajectories and their clinical implications in first-episode schizophrenia after one year of antipsychotic treatment.
    Schizophr Res. 2022;241:292-297.
    PubMed     Abstract available

  72. LONG M, Stansfeld JL, Davies N, Crellin NE, et al
    A systematic review of social functioning outcome measures in schizophrenia with a focus on suitability for intervention research.
    Schizophr Res. 2022;241:275-291.
    PubMed     Abstract available

    Schizophrenia: Transcending old world shadows.
    Schizophr Res. 2022 Feb 18. pii: S0920-9964(22)00074.

  74. GORDON JA, Morris SE, Avenevoli S
    A framework for integration of dimensional and diagnostic approaches to the diagnosis of schizophrenia.
    Schizophr Res. 2022 Feb 18. pii: S0920-9964(22)00066.

  75. ZHANG L, Strauss GP
    Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia.
    Schizophr Res. 2022 Feb 17. pii: S0920-9964(22)00085.

  76. SCORIELS L, Genaro LT, Keffer S, Guimaraes AL, et al
    Changes in emotion processing and social cognition with auditory versus visual neuroscience-informed cognitive training in individuals with schizophrenia.
    Schizophr Res. 2022;241:267-274.
    PubMed     Abstract available

  77. MCHUGO M, Rogers BP, Avery SN, Armstrong K, et al
    Increased amplitude of hippocampal low frequency fluctuations in early psychosis: A two-year follow-up study.
    Schizophr Res. 2022;241:260-266.
    PubMed     Abstract available

  78. WEBER S, Scott JG, Chatterton ML
    Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review.
    Schizophr Res. 2022;241:251-259.
    PubMed     Abstract available

  79. ZHAO Y, Guan Q, Shi J, Sun J, et al
    Impaired central set point of thyroid homeostasis during quetiapine treatment in the acute phase of schizophrenia.
    Schizophr Res. 2022;241:244-250.
    PubMed     Abstract available

  80. KESHAVAN MS, Yassin W, Stone WS
    Conceptualizing psychosis as an information processing disorder: Signal, bandwidth, noise, and bias.
    Schizophr Res. 2022 Feb 14. pii: S0920-9964(22)00027.

  81. APPAJI A, Harish V, Korann V, Devi P, et al
    Deep learning model using retinal vascular images for classifying schizophrenia.
    Schizophr Res. 2022;241:238-243.
    PubMed     Abstract available

  82. OOMEN PP, Gangadin SS, Begemann MJH, Visser E, et al
    The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders.
    Schizophr Res. 2022;241:228-237.
    PubMed     Abstract available

  83. TANDON R, Greden JF
    Reconstructing schizophrenia: Lessons from major mood disorders.
    Schizophr Res. 2022 Feb 12. pii: S0920-9964(22)00070.

  84. ADANTY C, Qian J, Wang Y, Remington G, et al
    Childhood trauma exposure and personality traits in schizophrenia patients.
    Schizophr Res. 2022;241:221-227.
    PubMed     Abstract available

  85. MOSCARELLI M, Min JY, Kopelowicz A, Chavez O, et al
    The "PRE" scale: The assessment of the elementary passively received experiences of schizophrenia.
    Schizophr Res. 2022;241:218-220.

  86. GUREJE O, Ojagbemi A
    Applicability and future status of schizophrenia as a construct in Africa.
    Schizophr Res. 2022 Feb 9. pii: S0920-9964(22)00033.
    PubMed     Abstract available

  87. STEINER J, Dobrowolny H, Guest PC, Bernstein HG, et al
    Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?
    Schizophr Res. 2022 Feb 9. pii: S0920-9964(22)00058.

  88. KOTOV R, Jonas KG, Lian W, Docherty AR, et al
    Reconceptualizing schizophrenia in the Hierarchical Taxonomy Of Psychopathology (HiTOP).
    Schizophr Res. 2022 Feb 7. pii: S0920-9964(22)00064.
    PubMed     Abstract available

  89. MAMAH D, Mutiso VN, Ndetei DM
    Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion.
    Schizophr Res. 2022;241:201-209.
    PubMed     Abstract available

  90. ZHANG Y, Zhang CY, Yuan J, Zeng XZ, et al
    Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients.
    Schizophr Res. 2022;241:197-200.

  91. BASSETT D, Boyce P, Lyndon B, Mulder R, et al
    Guidelines for the management of psychosis in the context of mood disorders.
    Schizophr Res. 2022;241:187-196.
    PubMed     Abstract available

  92. LO KYH, Hopman HJ, Chan SC, Chau WHS, et al
    Concurrent anodal transcranial direct current stimulation (tDCS) with cognitive training to improve cognition in schizophrenia.
    Schizophr Res. 2022;241:184-186.

  93. FATHIAN F, Gjestad R, Kroken RA, Loberg EM, et al
    Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
    Schizophr Res. 2022;241:174-183.
    PubMed     Abstract available

    What can genetics tell us about the schizophrenia construct?
    Schizophr Res. 2022 Feb 3. pii: S0920-9964(21)00492.

  95. JAVITT DC, Kantrowitz JT
    The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease.
    Schizophr Res. 2022 Feb 3. pii: S0920-9964(22)00023.
    PubMed     Abstract available

  96. DAZZAN P
    Is our mistake trying to identify a "homogeneous" schizophrenia construct?
    Schizophr Res. 2022 Feb 3. pii: S0920-9964(22)00067.

  97. GIORDANO GM, Palumbo D, Mucci A, Ventura J, et al
    The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia.
    Schizophr Res. 2022;241:161-170.
    PubMed     Abstract available

  98. O'DONOGHUE B, Polari A, McGorry P, Nelson B, et al
    Young migrants to Australia identified as being at ultra-high risk for psychosis: Pathways to care and clinical characteristics.
    Schizophr Res. 2022;241:156-160.
    PubMed     Abstract available

  99. TAMMINGA CA, Pearlson G, Gershon E, Keedy S, et al
    Using psychosis biotypes and the Framingham model for parsing psychosis biology.
    Schizophr Res. 2022 Feb 2. pii: S0920-9964(22)00028.
    PubMed     Abstract available

  100. KAHN RS
    Retroverting schizophrenia.
    Schizophr Res. 2022 Feb 2. pii: S0920-9964(22)00050.

  101. HUMPHREY C, Berry K, Degnan A, Bucci S, et al
    Childhood interpersonal trauma and paranoia in psychosis: The role of disorganised attachment and negative schema.
    Schizophr Res. 2022;241:142-148.
    PubMed     Abstract available

  102. DIAZ E, Estric C, Schandrin A, Lopez-Castroman J, et al
    Neurocognitive functioning and impulsivity in first-episode psychosis with suicidal ideation and behavior: A systematic review.
    Schizophr Res. 2022;241:130-139.
    PubMed     Abstract available

  103. KESHAVAN MS, Ongur D, Srihari VH
    Toward an expanded and personalized approach to coordinated specialty care in early course psychoses.
    Schizophr Res. 2022;241:119-121.

  104. KUSUDO K, Ochi R, Nakajima S, Suzuki T, et al
    Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia.
    Schizophr Res. 2022;241:113-115.

  105. CAQUEO-URIZAR A, Mena-Chamorro P, Urzua A, Peroza E, et al
    Psychotic symptomatology and medication adherence in patients with schizophrenia: The mediating effect of awareness of mental disorder.
    Schizophr Res. 2022;241:110-112.

  106. SAGUE-VILAVELLA M, Lopez-Pelayo H, Arbelo N, Camara M, et al
    Clozapine toxicity and coronavirus disease 2019: A case report.
    Schizophr Res. 2022;240:184-185.

  107. ANDRADE C, Suhas S
    Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics.
    Schizophr Res. 2022;240:204.

  108. BA MB, Curtis L, Pellizzer G
    Viewer and object mental rotation in young adults with psychotic disorders.
    Schizophr Res. 2022;240:92-102.
    PubMed     Abstract available

  109. HOWELLS FM, Hsieh JH, Temmingh HS, Baldwin DS, et al
    Capacity for cortical excitation is reduced in psychotic disorders: An investigation of the TMS-EMG cortical silent period.
    Schizophr Res. 2022;240:73-77.

    January 2022
  110. VAN DER HEIJDEN HS, Schirmbeck F, Berry L, Simons CJP, et al
    Impact of coping styles on substance use in persons with psychosis, siblings, and controls.
    Schizophr Res. 2022;241:102-109.
    PubMed     Abstract available

  111. BURKE T, Thompson A, Mifsud N, Yung AR, et al
    Proportion and characteristics of young people in a first-episode psychosis clinic who first attended an at-risk mental state service or other specialist youth mental health service.
    Schizophr Res. 2022;241:94-101.
    PubMed     Abstract available

  112. TREVISAN N, Miola A, Cattarinussi G, Kubera KM, et al
    Cortical folding complexity is distinctively altered in schizophrenia and bipolar disorder.
    Schizophr Res. 2022;241:92-93.

  113. BILGRAMI ZR, Sarac C, Srivastava A, Herrera SN, et al
    Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings.
    Schizophr Res. 2022 Jan 27. pii: S0920-9964(22)00029.
    PubMed     Abstract available

  114. BRIDGWATER MA, Horton LE, Haas GL
    Premorbid adjustment in childhood is associated with later emotion management in first-episode schizophrenia.
    Schizophr Res. 2022;240:233-238.
    PubMed     Abstract available

  115. RIKANDI E, Mantyla T, Lindgren M, Kieseppa T, et al
    Functional network connectivity and topology during naturalistic stimulus is altered in first-episode psychosis.
    Schizophr Res. 2022;241:83-91.
    PubMed     Abstract available

  116. YATES K, Lang U, Peters EM, Wigman JTW, et al
    Sexual assault and psychosis in two large general population samples: Is childhood and adolescence a developmental window of sensitivity?
    Schizophr Res. 2022;241:78-82.
    PubMed     Abstract available

  117. MERCHANT JT, Moran EK, Barch DM
    Negative and depressive symptoms differentially relate to real-world anticipatory and consummatory pleasure in schizophrenia.
    Schizophr Res. 2022;241:72-77.
    PubMed     Abstract available

  118. MOTOYAMA M, Yamada H, Maebayashi K, Yoshimura C, et al
    Efficacy of a gluten-restricted diet in treatment-resistant schizophrenia patients with immunological gluten sensitivity: A case report.
    Schizophr Res. 2022;241:68-69.

  119. KISHI T, Nakamura H, Matsuura A, Iwata N, et al
    Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia.
    Schizophr Res. 2022;240:231-232.

  120. WALKER EF, Goldsmith DR
    Schizophrenia: A scientific graveyard or a pragmatically useful diagnostic construct?
    Schizophr Res. 2022 Jan 25. pii: S0920-9964(22)00032.

  121. RANGASWAMY T, Arunachalam P, Raghavan V, John S, et al
    Schizophrenia construct: Quandaries and conundrums in India and LAMIC.
    Schizophr Res. 2022 Jan 25. pii: S0920-9964(22)00024.
    PubMed     Abstract available

    Schizophrenia as a categorical diagnosis: A view from the neural risk architecture.
    Schizophr Res. 2022 Jan 24. pii: S0920-9964(22)00031.
    PubMed     Abstract available

  123. THIRTHALLI J, Mehta UM, Keshav Kumar JK, Tyagi V, et al
    Randomized, sham-controlled trial of transcranial magnetic stimulation augmentation of cognitive remediation in schizophrenia.
    Schizophr Res. 2022;241:63-65.

  124. COLIJN MA, Torres IJ, Menon M, Howard A, et al
    Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians.
    Schizophr Res. 2022;241:59-62.

  125. AZZALI S, Pelizza L, Scazza I, Paterlini F, et al
    Examining subjective experience of aberrant salience in young individuals at ultra-high risk (UHR) of psychosis: A 1-year longitudinal study.
    Schizophr Res. 2022;241:52-58.
    PubMed     Abstract available

  126. TSUKAHARA M, So R, Nomura N, Kitagawa K, et al
    Association between subjective distress and symptom domains in patients with treatment-resistant schizophrenia receiving clozapine.
    Schizophr Res. 2022;240:228-230.

  127. GROVER S, Rani S, Kohat K, Kathiravan S, et al
    First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report.
    Schizophr Res. 2022;241:70-71.

  128. NOGOVITSYN N, Metzak PD, Casseb RF, Souza R, et al
    Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis.
    Schizophr Res. 2022;240:220-227.
    PubMed     Abstract available

  129. TOUFEILI A, Cohen E, Ray JG, Wilton AS, et al
    Complex chronic conditions among children born to women with schizophrenia.
    Schizophr Res. 2022;241:24-35.
    PubMed     Abstract available

  130. PIGONI A, Delvecchio G, Dusi N, Schiena G, et al
    Insula volumes in first-episode and chronic psychosis: A longitudinal MRI study.
    Schizophr Res. 2022;241:14-23.
    PubMed     Abstract available

  131. TANDON R
    Agreement on the contours of schizophrenia: The first order of business.
    Schizophr Res. 2022 Jan 20. pii: S0920-9964(22)00003.

  132. KELLY DL, Buchanan RW
    Can the current schizophrenia construct endure?
    Schizophr Res. 2022 Jan 20. pii: S0920-9964(21)00512.

  133. ZICK JL, Staglin B, Vinogradov S
    Eliminate schizophrenia.
    Schizophr Res. 2022 Jan 20. pii: S0920-9964(22)00004.
    PubMed     Abstract available

  134. SUHAS S, Sreeraj VS, Amrutha C, Desai G, et al
    Is allopurinol a marvel in the endgame of ultra-resistant schizophrenia?
    Schizophr Res. 2022;241:12-13.

  135. BROGNA P, Brogna C, Santomassimo C, Romeo D, et al
    Shades of shame: Embarrassment as a covert marker of self-stigma in a sample case study of patients with schizophrenia.
    Schizophr Res. 2022;241:10-11.

  136. SIZER H, Brown E, Geros H, Yung A, et al
    Outcomes for first-episode psychosis after entry via an at-risk mental state clinic compared to direct entry to a first episode of psychosis service: A systematic review and meta-analysis.
    Schizophr Res. 2022;240:214-219.
    PubMed     Abstract available

  137. CORRELL CU, Tocco M, Pikalov A, Hsu J, et al
    Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naive versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
    Schizophr Res. 2022;240:205-213.
    PubMed     Abstract available

  138. ANTONUCCI LA, Fazio L, Pergola G, Blasi G, et al
    Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia.
    Schizophr Res. 2022;240:193-203.
    PubMed     Abstract available

  139. VAN GOOL KCA, Collin G, Bauer CCC, Molokotos E, et al
    Altered working memory-related brain activity in children at familial high risk for psychosis: A preliminary study.
    Schizophr Res. 2022;240:186-192.
    PubMed     Abstract available

  140. GAEBEL W, Salveridou-Hof E
    Reinventing schizophrenia: Updating the construct - Primary schizophrenia 2021 - The road ahead.
    Schizophr Res. 2022 Jan 12. pii: S0920-9964(21)00505.
    PubMed     Abstract available

  141. GUR RE
    Considering alternatives to the schizophrenia construct.
    Schizophr Res. 2022 Jan 12. pii: S0920-9964(21)00511.

  142. CHU MH, Lau B, Leung J, Chan SC, et al
    Positive psychotherapy for psychosis in Hong Kong: A randomized controlled trial.
    Schizophr Res. 2022;240:175-183.
    PubMed     Abstract available

  143. JIAO X, Hu Q, Tang Y, Qian Z, et al
    Test-retest reliability of mismatch negativity and gamma-band auditory steady-state response in patients with schizophrenia.
    Schizophr Res. 2022;240:165-174.
    PubMed     Abstract available

  144. GREEN MF, Jimenez AM
    Clinical observations and neuroscientific evidence tell a similar story: Schizophrenia is a disorder of the self-other boundary.
    Schizophr Res. 2022 Jan 10. pii: S0920-9964(21)00516.

  145. VON MALACHOWSKI A, Schlier B, Austin SF, Frost M, et al
    IMPACHS: Feasibility and acceptability of an m-health solution integrated into routine clinical treatment for psychosis.
    Schizophr Res. 2022;240:150-152.

  146. ZHU R, Wang D, Tian Y, Du Y, et al
    Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia.
    Schizophr Res. 2022;240:143-149.
    PubMed     Abstract available

  147. BARTOLOMEO LA, Raugh IM, Strauss GP
    Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics.
    Schizophr Res. 2022;240:135-142.
    PubMed     Abstract available

  148. CHOI S, Kim M, Park H, Kim T, et al
    Volume deficits in hippocampal subfields in unaffected relatives of schizophrenia patients with high genetic loading but without any psychiatric symptoms.
    Schizophr Res. 2022;240:125-131.
    PubMed     Abstract available

  149. MCCUTCHEON RA, McGuire P
    Reinventing schizophrenia: The rules of the game.
    Schizophr Res. 2022 Jan 5. pii: S0920-9964(21)00493.

  150. PARK S, Baxter T
    Schizophrenia in the flesh: Revisiting schizophrenia as a disorder of the bodily self.
    Schizophr Res. 2022 Jan 4. pii: S0920-9964(21)00515.

  151. RUDOLPH A, Liepelt R, Kaffes M, Hofmann-Shen C, et al
    Motor cognition in schizophrenia: Control of automatic imitation and mapping of action context are reduced.
    Schizophr Res. 2022;240:116-124.
    PubMed     Abstract available

  152. VAN OS J, Guloksuz S
    Schizophrenia as a symptom of psychiatry's reluctance to enter the moral era of medicine.
    Schizophr Res. 2022 Jan 3. pii: S0920-9964(21)00501.
    PubMed     Abstract available

  153. SAWA A, Yang K, Cascella NG
    Paradigm shift on the concept of schizophrenia that matches with both academic and clinical needs.
    Schizophr Res. 2022 Jan 3. pii: S0920-9964(21)00506.

  154. REICHENBERG A, Akbarian S
    Towards DSM 10: A bio-classification of developmental schizophrenia?
    Schizophr Res. 2022 Jan 3. pii: S0920-9964(21)00490.

  155. JIMENEZ-LOPEZ E, Villanueva-Romero CM, Sanchez-Morla EM, Martinez-Vizcaino V, et al
    Neurocognition, functional outcome, and quality of life in remitted and non-remitted schizophrenia: A comparison with euthymic bipolar I disorder and a control group.
    Schizophr Res. 2022;240:81-91.
    PubMed     Abstract available

  156. SCHANDRIN A, Picot MC, Marin G, Andre M, et al
    Video self-confrontation as a therapeutic tool in schizophrenia: A randomized parallel-arm single-blind trial.
    Schizophr Res. 2022;240:103-112.
    PubMed     Abstract available

  157. DE WINTER L, Couwenbergh C, van Weeghel J, Hasson-Ohayon I, et al
    Changes in social functioning over the course of psychotic disorders-A meta-analysis.
    Schizophr Res. 2022;239:55-82.
    PubMed     Abstract available

  158. FOTIA F, Van Dam L, Sykes JJ, Ambrosini E, et al
    Body structural representation in schizotypy.
    Schizophr Res. 2022;239:1-10.
    PubMed     Abstract available

    December 2021
  159. KEANE BP, Erlikhman G, Serody M, Silverstein SM, et al
    A brief psychometric test reveals robust shape completion deficits in schizophrenia that are less severe in bipolar disorder.
    Schizophr Res. 2021;240:78-80.

    Schizophrenia: A view of immediate future.
    Schizophr Res. 2021 Dec 27. pii: S0920-9964(21)00488.

  161. MARTINEZ-ALES G, Susser ES
    A useful construct to improve the lives of people with schizophrenia.
    Schizophr Res. 2021 Dec 27. pii: S0920-9964(21)00494.

  162. GUO C, Li J, Guo M, Bai R, et al
    Aberrant expressions of MIAT and PVT1 in serum exosomes of schizophrenia patients.
    Schizophr Res. 2021;240:71-72.

  163. FRANGOU S
    Schizophrenia: More data, less debate.
    Schizophr Res. 2021 Dec 22. pii: S0920-9964(21)00498.

  164. MURRAY RM, Quattrone D
    The Kraepelian concept of schizophrenia: Dying but not yet dead.
    Schizophr Res. 2021 Dec 21. pii: S0920-9964(21)00489.

  165. RAHMAN T, Purves-Tyson T, Geddes AE, Huang XF, et al
    N-Methyl-d-Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2021;240:61-70.
    PubMed     Abstract available

  166. HERNIMAN SE, Wood SJ, Cotton SM, Allott KA, et al
    The specific phenotype of depression in recent onset schizophrenia spectrum disorders: A symptom profile and network comparison to recent onset major depressive disorder without psychotic features.
    Schizophr Res. 2021;240:52-60.
    PubMed     Abstract available

  167. GALDERISI S, Giordano GM
    We are not ready to abandon the current schizophrenia construct, but should be prepared to do so.
    Schizophr Res. 2021 Dec 16. pii: S0920-9964(21)00491.
    PubMed     Abstract available

  168. RAKHSHAN ROUHAKHTAR P, Roemer C, Reeves G, Schiffman J, et al
    The associations between attenuated psychosis symptoms and functioning in Black and White youth at clinical high-risk for psychosis.
    Schizophr Res. 2021 Dec 15. pii: S0920-9964(21)00453.
    PubMed     Abstract available

  169. CANNON TD
    Psychosis, schizophrenia, and states vs. traits.
    Schizophr Res. 2021 Dec 14. pii: S0920-9964(21)00485.
    PubMed     Abstract available

  170. PORTER L, Jones C, Fox A
    Reliability of the Calgary depression scale for schizophrenia: A meta-analysis.
    Schizophr Res. 2021;240:32-45.
    PubMed     Abstract available

  171. ZHOU D, Xie C, Li X, Song N, et al
    Rare presence of autoantibodies targeting to NMDA and GABAA receptors in schizophrenia patients.
    Schizophr Res. 2021 Dec 13. pii: S0920-9964(21)00486.
    PubMed     Abstract available

    The term "psychosis" is archaic.
    Schizophr Res. 2021;240:31.

  173. XENAKI LA, Stefanatou P, Ralli E, Hatzimanolis A, et al
    The relationship between early symptom severity, improvement and remission in first episode psychosis with jumping to conclusions.
    Schizophr Res. 2021;240:24-30.
    PubMed     Abstract available

  174. TANDON R
    Putting the cart before the horse. Schizophrenia does need a name change, but the time is not right.
    Schizophr Res. 2021;240:22-23.

  175. PRASAD K, Rubin J, Mitra A, Lewis M, et al
    Structural covariance networks in schizophrenia: A systematic review Part I.
    Schizophr Res. 2021;240:1-21.
    PubMed     Abstract available

    Psychosis and fever revisited.
    Schizophr Res. 2021 Dec 10. pii: S0920-9964(21)00445.

  177. FRUTH S, Brieden A, Leucht S, Heres S, et al
    New insight into the CATIE study by constrained confidence partitioning. An innovative technique towards personalized antipsychotic drug therapy in schizophrenia treatment.
    Schizophr Res. 2021;239:192-199.
    PubMed     Abstract available

  178. PRASAD K, Rubin J, Mitra A, Lewis M, et al
    Structural covariance networks in schizophrenia: A systematic review Part II.
    Schizophr Res. 2021;239:176-191.
    PubMed     Abstract available

  179. YU Y, Shen M, Niu L, Liu YE, et al
    The relationship between clinical recovery and personal recovery among people living with schizophrenia: A serial mediation model and the role of disability and quality of life.
    Schizophr Res. 2021;239:168-175.
    PubMed     Abstract available

  180. RAJJI TK, Mamo DC, Holden J, Granholm E, et al
    Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction.
    Schizophr Res. 2021;239:160-167.
    PubMed     Abstract available

  181. TORREGROSSA LJ, Amedy A, Roig J, Prada A, et al
    Interoceptive functioning in schizophrenia and schizotypy.
    Schizophr Res. 2021;239:151-159.
    PubMed     Abstract available

  182. BARCH DM, Karcher N, Moran E
    Reinventing schizophrenia - Embracing complexity and complication.
    Schizophr Res. 2021 Dec 7. pii: S0920-9964(21)00468.
    PubMed     Abstract available

  183. NAVALON P, Sahuquillo-Leal R, Moreno-Gimenez A, Salmeron L, et al
    Attentional engagement and inhibitory control according to positive and negative symptoms in schizophrenia: An emotional antisaccade task.
    Schizophr Res. 2021;239:142-150.
    PubMed     Abstract available

  184. BERNARDIN F, Schwitzer T, Schwan R, Angioi-Duprez K, et al
    Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia.
    Schizophr Res. 2021;239:134-141.
    PubMed     Abstract available

  185. RUBIN LH, Han J, Coughlin JM, Hill SK, et al
    Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study.
    Schizophr Res. 2021 Dec 6. pii: S0920-9964(21)00448.
    PubMed     Abstract available

  186. KISELY S, Strathearn L, Najman JM
    A comparison of psychosis-like symptoms following self-reported and agency-notified child abuse in a population-based birth cohort at 30-year-follow-up.
    Schizophr Res. 2021;239:116-122.
    PubMed     Abstract available

  187. KONG L, Lui SSY, Wang Y, Hung KSY, et al
    Structural network alterations and their association with neurological soft signs in schizophrenia: Evidence from clinical patients and unaffected siblings.
    Schizophr Res. 2021 Dec 4. pii: S0920-9964(21)00475.
    PubMed     Abstract available

  188. GOTRA MY, Keedy SK, Hill SK
    Interactive effects of maintenance decay and interference on working memory updating in schizophrenia.
    Schizophr Res. 2021;239:103-110.
    PubMed     Abstract available

  189. DELISI LE
    Redefining schizophrenia through genetics: A commentary on 50 years searching for biological causes.
    Schizophr Res. 2021 Dec 3. pii: S0920-9964(21)00437.
    PubMed     Abstract available

  190. LUDTKE T, Moritz S, Westermann S, Pfuhl G, et al
    Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis.
    Schizophr Res. 2021 Dec 3. pii: S0920-9964(21)00430.

  191. VAN DER TUIN S, Balafas SE, Oldehinkel AJ, Wit EC, et al
    Dynamic symptom networks across different at-risk stages for psychosis: An individual and transdiagnostic perspective.
    Schizophr Res. 2021;239:95-102.
    PubMed     Abstract available

  192. KENDLER KS, Heckers S
    The schizophrenia concept (for schizophrenia research special issue).
    Schizophr Res. 2021 Dec 2. pii: S0920-9964(21)00454.

  193. KESHAVAN MS, Davis B, Friedman-Yakoobian M, Mesholam-Gately RI, et al
    What is my diagnosis, Doc?: Discussing psychosis diagnosis with patients and families.
    Schizophr Res. 2021;239:92-94.

  194. DONALDSON KR, Larsen EM, Jonas K, Tramazzo S, et al
    Mismatch negativity amplitude in first-degree relatives of individuals with psychotic disorders: Links with cognition and schizotypy.
    Schizophr Res. 2021;238:161-169.
    PubMed     Abstract available

  195. QUIDE Y, Tonini E, Watkeys OJ, Carr VJ, et al
    Schizotypy, childhood trauma and brain morphometry.
    Schizophr Res. 2021;238:73-81.
    PubMed     Abstract available

    November 2021
  196. FILTS Y, Litman RE, Martinez J, Anta L, et al
    Long-term efficacy and safety of once-monthly Risperidone ISM(R) in the treatment of schizophrenia: Results from a 12-month open-label extension study.
    Schizophr Res. 2021;239:83-91.
    PubMed     Abstract available

  197. LEWIS DA, Dienel SJ, Chung DW
    Searching for the "final proof" of schizophrenia.
    Schizophr Res. 2021 Nov 26. pii: S0920-9964(21)00446.

  198. ZHU X, Fan H, Zou Y, Tan Y, et al
    Computerized or manual? Long term effects of cognitive remediation on schizophrenia.
    Schizophr Res. 2021;239:47-54.
    PubMed     Abstract available

  199. JOHNSON KA, Shrier LA, Eiduson R, Parsa N, et al
    Depressive symptom screening and endorsement of psychosis risk-related experiences in a diverse adolescent and young adult outpatient clinic in the US.
    Schizophr Res. 2021 Nov 25. pii: S0920-9964(21)00447.
    PubMed     Abstract available

  200. CARPINIELLO B, Pinna F, Manchia M, Tusconi M, et al
    Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.
    Schizophr Res. 2021;239:34-41.
    PubMed     Abstract available

  201. MILLER BJ, McEvoy JP, McCall WV, Harris RA, et al
    Insomnia and triglycerides in schizophrenia.
    Schizophr Res. 2021;239:42-43.

  202. SUHAS S, Rao NP
    Personal protective equipment in the emergency room and schizophrenia - Implications beyond safety.
    Schizophr Res. 2021;239:32-33.

  203. OLUWOYE O, Stokes B
    The unique pathways to coordinate specialty care for Black families navigating early psychosis: A preliminary report.
    Schizophr Res. 2021 Nov 22. pii: S0920-9964(21)00425.
    PubMed     Abstract available

  204. LI Z, Zhang T, Xu L, Wei Y, et al
    Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis.
    Schizophr Res. 2021;239:19-28.
    PubMed     Abstract available

  205. CERNIS E, Molodynski A, Ehlers A, Freeman D, et al
    Dissociation in patients with non-affective psychosis: Prevalence, symptom associations, and maintenance factors.
    Schizophr Res. 2021;239:11-18.
    PubMed     Abstract available

    To change the label of schizophrenia, first revise the construct.
    Schizophr Res. 2021;238:201-202.

  207. SANDOVAL LR, Stone L, Guimond S, Lawler A, et al
    Encapsulating psychosis with a second language: A clinical case.
    Schizophr Res. 2021 Nov 17. pii: S0920-9964(21)00422.
    PubMed     Abstract available

  208. MOTA NB
    Commentary on "Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations": The current need for the harmonization of speech elicitation protocols in basic and applied science.
    Schizophr Res. 2021;238:199-200.

    Re-inventing the schizophrenia syndrome: The elusive "theory of everything".
    Schizophr Res. 2021 Nov 16. pii: S0920-9964(21)00427.

  210. WADDINGTON JL, Nkire N, Russell V
    Schizophrenia vis-a-vis dimensional-spectrum concepts of psychotic illness: Has an answer been 'hiding in plain sight'?
    Schizophr Res. 2021 Nov 16. pii: S0920-9964(21)00433.

  211. JOHNSON MC, Baum ML, Lizano P
    Falling through the cracks: Missed opportunities for diagnosing and treating lupus in schizophrenia.
    Schizophr Res. 2021;238:185-187.

    October 2021
  212. OWEN MJ, Legge SE
    The nature of schizophrenia: As broad as it is long.
    Schizophr Res. 2021 Oct 28. pii: S0920-9964(21)00409.

  213. SEABURY RD, Bearden CE, Ventura J, Subotnik KL, et al
    Confident memory errors and disrupted reality testing in early psychosis.
    Schizophr Res. 2021;238:170-177.
    PubMed     Abstract available

  214. MESHOLAM-GATELY RI, Varca N, Spitzer C, Parrish EM, et al
    Are we ready for a name change for schizophrenia? A survey of multiple stakeholders.
    Schizophr Res. 2021;238:152-160.
    PubMed     Abstract available

  215. LEATHEM LD, Currin DL, Montoya AK, Karlsgodt KH, et al
    Socioemotional mechanisms of loneliness in subclinical psychosis.
    Schizophr Res. 2021;238:145-151.
    PubMed     Abstract available

  216. KU BS, Addington J, Bearden CE, Cadenhead KS, et al
    Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium.
    Schizophr Res. 2021;238:137-144.
    PubMed     Abstract available

  217. CATALANO LT, Wynn JK, Lee J, Green MF, et al
    A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study.
    Schizophr Res. 2021;238:128-136.
    PubMed     Abstract available

  218. VOGEL JS, Bruins J, de Jong S, Knegtering H, et al
    Satisfaction with social connectedness as a predictor for positive and negative symptoms of psychosis: A PHAMOUS study.
    Schizophr Res. 2021;238:121-127.
    PubMed     Abstract available

  219. BASAVARAJU R, Ithal D, Thanki MV, Ramalingaiah AH, et al
    Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled trial.
    Schizophr Res. 2021;238:108-120.
    PubMed     Abstract available

  220. NARITA Z, Yang K, Kuga H, Piancharoen P, et al
    Face processing of social cognition in patients with first episode psychosis: Its deficits and association with the right subcallosal anterior cingulate cortex.
    Schizophr Res. 2021;238:99-107.
    PubMed     Abstract available

  221. TAN EJ, Meyer D, Neill E, Rossell SL, et al
    Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations.
    Schizophr Res. 2021;238:91-98.
    PubMed     Abstract available

  222. NORRA C, Ueberberg B, Juckel G
    A new electronically based clinical pathway for schizophrenia inpatients: A longitudinal pilot study.
    Schizophr Res. 2021;238:82-90.
    PubMed     Abstract available

  223. MCGRATH JJ, Wray NR
    Seven short reflections on the notion of schizophrenia.
    Schizophr Res. 2021 Oct 8. pii: S0920-9964(21)00396.

  224. JOE P, Clemente JC, Piras E, Wallach DS, et al
    An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth.
    Schizophr Res. 2021 Oct 5. pii: S0920-9964(21)00389.
    PubMed     Abstract available

  225. PUTHOTA J, Alatorre A, Walsh S, Clemente JC, et al
    Prenatal ambient temperature and risk for schizophrenia.
    Schizophr Res. 2021 Oct 4. pii: S0920-9964(21)00390.
    PubMed     Abstract available

  226. FELDMAN J, Hamlyn A, Rice T
    Social media in screening and monitoring for early intervention in psychosis.
    Schizophr Res. 2021;238:70-72.

  227. GOLAY P, Ramain J, Jenni R, Klauser P, et al
    Six months functional response to early psychosis intervention program best predicts outcome after three years.
    Schizophr Res. 2021;238:62-69.
    PubMed     Abstract available

  228. ESKRIDGE CLM, Hochberger WC, Kaseda ET, Lencer R, et al
    Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.
    Schizophr Res. 2021;236:54-60.
    PubMed     Abstract available

  229. KALIUZHNA M, Kirschner M, Carruzzo F, Hartmann-Riemer MN, et al
    How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain.
    Schizophr Res. 2021;236:41-47.
    PubMed     Abstract available

    September 2021
  230. KOSUGI N, Oshiyama C, Kodama N, Niwa SI, et al
    Predictability of a favorable outcome in schizophrenia associated with positive effects of "music therapy incorporated into cognitive remediation".
    Schizophr Res. 2021;238:52-53.

  231. WOODBERRY KA, Powers KS, Bryant C, Downing D, et al
    Emotional and stigma-related experiences relative to being told one is at risk for psychosis.
    Schizophr Res. 2021;238:44-51.
    PubMed     Abstract available

  232. CHESNEY E, Robson D, Patel R, Shetty H, et al
    The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study.
    Schizophr Res. 2021;238:29-35.
    PubMed     Abstract available

  233. PAVITHRA A, Durairaj J, Raghavan V
    No association between advanced paternal age and age of onset of illness among patients with schizophrenia: A cross-sectional study from South India.
    Schizophr Res. 2021;238:27-28.

  234. HAHN S, Moritz S, Elmers J, Scheunemann J, et al
    Do you like cliff-hangers? Objective versus subjective need for closure in the schizophrenia spectrum.
    Schizophr Res. 2021;238:20-26.
    PubMed     Abstract available

  235. TAKEUCHI H, Sanches M, Borlido C, Agid O, et al
    Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implications.
    Schizophr Res. 2021;237:202-207.
    PubMed     Abstract available

  236. LEE YJ, Huang SY, Lin CP, Tsai SJ, et al
    Alteration of power law scaling of spontaneous brain activity in schizophrenia.
    Schizophr Res. 2021;238:10-19.
    PubMed     Abstract available

  237. ROSEN C, Harrow M, Tong L, Jobe TH, et al
    A word is worth a thousand pictures: A 20-year comparative analysis of aberrant abstraction in schizophrenia, affective psychosis, and non-psychotic depression.
    Schizophr Res. 2021;238:1-9.
    PubMed     Abstract available

  238. OSPINA LH, Beck-Felts K, Ifrah C, Shagalow S, et al
    Relationships among inflammation, social cognition, and social functioning in schizophrenia.
    Schizophr Res. 2021 Sep 22. pii: S0920-9964(21)00362.

  239. KRISTENSEN TD, Glenthoj LB, Ragahava JM, Syeda W, et al
    Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis.
    Schizophr Res. 2021;237:192-201.
    PubMed     Abstract available

  240. ESCOLA-GASCON A, Wright AC
    Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis?
    Schizophr Res. 2021;237:190-191.

  241. SENGUTTA M, Karow A, Gaweda L
    Anomalous self-experiences (ASE) in relation to clinical high risk for psychosis (CHRP), childhood trauma and general psychopathology among adolescent and young adult help seekers.
    Schizophr Res. 2021;237:182-189.
    PubMed     Abstract available

  242. TAKAHASHI T, Sasabayashi D, Takayanagi Y, Furuichi A, et al
    Altered Heschl's gyrus duplication pattern in first-episode schizophrenia.
    Schizophr Res. 2021;237:174-181.
    PubMed     Abstract available

  243. CHEN YM, Chen HK, Wu BJ, Chen IC, et al
    Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia.
    Schizophr Res. 2021;237:166-173.
    PubMed     Abstract available

  244. MEHTA UM, Ibrahim FA, Sharma MS, Venkatasubramanian G, et al
    Resting-state functional connectivity predictors of treatment response in schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;237:153-165.
    PubMed     Abstract available

  245. FOX V, Sheffield JM, Woodward ND
    Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms.
    Schizophr Res. 2021;237:141-147.
    PubMed     Abstract available

  246. SUETANI S, Honarparvar F, Siskind D, Hindley G, et al
    Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls.
    Schizophr Res. 2021;237:131-140.
    PubMed     Abstract available

  247. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Lorente-Omenaca R, et al
    A network analysis and empirical validation of executive deficits in patients with psychosis and their healthy siblings.
    Schizophr Res. 2021;237:122-130.
    PubMed     Abstract available

  248. ROKITA KI, Dauvermann MR, Mothersill D, Holleran L, et al
    Current psychosocial stress, childhood trauma and cognition in patients with schizophrenia and healthy participants.
    Schizophr Res. 2021;237:115-121.
    PubMed     Abstract available

  249. TAO TJ, Hui CLM, Lam BST, Ho ECN, et al
    Mindfulness meditation for Chinese patients with psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2021;237:103-114.
    PubMed     Abstract available

  250. PAREDES R, Ferri F, Series P
    Influence of E/I balance and pruning in peri-personal space differences in schizophrenia: A computational approach.
    Schizophr Res. 2021 Sep 8. pii: S0920-9964(21)00238.
    PubMed     Abstract available

  251. SHIMOMURA Y, Kikuchi Y, Suzuki T, Uchida H, et al
    Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms.
    Schizophr Res. 2021;236:142-155.
    PubMed     Abstract available

  252. POLARI A, Street R, Conus P, Finkelstein A, et al
    Patients', carers' and clinicians' attitudes towards alternative terms to describe the at-risk for psychosis state.
    Schizophr Res. 2021;237:69-75.
    PubMed     Abstract available

  253. LURIE I, Shoval G, Hoshen M, Balicer R, et al
    The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study.
    Schizophr Res. 2021;237:62-68.
    PubMed     Abstract available

  254. O'DRISCOLL C, Shaikh M, Finamore C, Platt B, et al
    Profiles and trajectories of mental health service utilisation during early intervention in psychosis.
    Schizophr Res. 2021;237:47-53.
    PubMed     Abstract available

  255. MOLINA JL, Joshi YB, Nungaray JA, Thomas ML, et al
    Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training.
    Schizophr Res. 2021;236:135-141.
    PubMed     Abstract available

  256. SEPPALA A, Pylvanainen J, Lehtiniemi H, Hirvonen N, et al
    Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;236:123-134.
    PubMed     Abstract available

  257. VAN DUIN D, de Winter L, Kroon H, Veling W, et al
    Effects of IPS plus cognitive remediation in early psychosis: 18-month functioning outcomes of a randomized controlled trial.
    Schizophr Res. 2021;236:115-122.
    PubMed     Abstract available

  258. GUPTA L, Hoffman KW
    Exploring the intersection of the microbiome and the developing brain: Impacts on schizophrenia risk.
    Schizophr Res. 2021 Sep 2. pii: S0920-9964(21)00325.
    PubMed     Abstract available

  259. ROSA PGP, Zugman A, Cerqueira CT, Serpa MH, et al
    Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification.
    Schizophr Res. 2021;236:104-114.
    PubMed     Abstract available

  260. AMORETTI S, Rabelo-da-Ponte FD, Rosa AR, Mezquida G, et al
    Cognitive clusters in first-episode psychosis.
    Schizophr Res. 2021;237:31-39.
    PubMed     Abstract available

  261. PATIL AN, Kasudhan KS, Naveen M, Batra GK, et al
    Precise pharmacogenetic pharmacometabolomic (PPP) guided clozapine therapy in treatment resistant schizophrenia: Insights from one ethnicity experiment.
    Schizophr Res. 2021;237:26-28.

  262. ZHU Y, Zhang C, Siafis S, Zhuo K, et al
    Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis.
    Schizophr Res. 2021;237:20-25.
    PubMed     Abstract available

  263. MAGUIRE PA, Reay RE, Looi JCL
    H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care.
    Schizophr Res. 2021;237:101-102.

    August 2021
  264. TANG CH, Ramcharran D, Yang CW, Chang CC, et al
    A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan.
    Schizophr Res. 2021;237:9-19.
    PubMed     Abstract available

  265. GIN K, Stewart C, Abbott C, Banerjea P, et al
    Psychosocial predictors of distressing unusual experiences in adolescence: Testing the fit of an adult cognitive model of psychosis.
    Schizophr Res. 2021;237:1-8.
    PubMed     Abstract available

  266. GIRARD JM, Vail AK, Liebenthal E, Brown K, et al
    Computational analysis of spoken language in acute psychosis and mania.
    Schizophr Res. 2021 Aug 26. pii: S0920-9964(21)00252.
    PubMed     Abstract available

  267. DE JAGER J, Topper M, Nugter A, van Os J, et al
    The impact of childhood sexual trauma on intimacy and sexuality needs among people with non-affective psychosis.
    Schizophr Res. 2021;236:97-103.
    PubMed     Abstract available

  268. IHLER HM, Lagerberg TV, Lyngstad SH, Melle I, et al
    Exploring the relationship between recency and frequency of cannabis use and diminished expression and apathy as two dimensions of negative symptoms in first episode psychosis. A one-year follow-up study.
    Schizophr Res. 2021;236:89-96.
    PubMed     Abstract available

  269. SANTESTEBAN-ECHARRI O, Liu L, Cadenhead KS, Tsuang MT, et al
    Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up.
    Schizophr Res. 2021;236:87-88.

  270. MILLER ML, Strassnig MT, Bromet E, Depp CA, et al
    Performance-based assessment of social skills in a large sample of participants with schizophrenia, bipolar disorder and healthy controls: Correlates of social competence and social appropriateness.
    Schizophr Res. 2021;236:80-86.
    PubMed     Abstract available

  271. FERRARO L, La Cascia C, La Barbera D, Sanchez-Gutierrez T, et al
    The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.
    Schizophr Res. 2021;236:69-79.
    PubMed     Abstract available

  272. ERICKSON MA, Hahn B, Kiat JE, Alliende LM, et al
    Neural basis of the visual working memory deficit in schizophrenia: Merging evidence from fMRI and EEG.
    Schizophr Res. 2021;236:61-68.
    PubMed     Abstract available

  273. VAN DER HEIJDEN HS, Schirmbeck F, McGuire P, Valmaggia LR, et al
    Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study.
    Schizophr Res. 2021;236:48-53.
    PubMed     Abstract available

  274. GROVER S, Kathiravan S, Suman A, Naskar C, et al
    Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India.
    Schizophr Res. 2021;236:38-40.

  275. WANG Y, Jiang Y, Collin G, Liu D, et al
    The effects of antipsychotics on interactions of dynamic functional connectivity in the triple-network in first episode schizophrenia.
    Schizophr Res. 2021;236:29-37.
    PubMed     Abstract available

  276. GONZALEZ-BLANCO L, Garcia-Portilla MP, Gutierrez M, Mezquida G, et al
    Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
    Schizophr Res. 2021;236:19-28.
    PubMed     Abstract available

  277. LUNSFORD-AVERY JR, Pelletier-Baldelli A, Korenic SA, Schiffman J, et al
    Eveningness chronotype preference among individuals at clinical high risk for psychosis.
    Schizophr Res. 2021;236:3-8.
    PubMed     Abstract available

  278. DESTE G, Vita A, Nibbio G, Barlati S, et al
    Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features.
    Schizophr Res. 2021;236:12-18.
    PubMed     Abstract available

  279. KLEIN-PETERSEN AW, Kohler-Forsberg O, Benros ME
    Infections, antibiotic treatment and the Microbiome in relation to schizophrenia.
    Schizophr Res. 2021;234:71-77.
    PubMed     Abstract available

  280. NGUYEN TT, Hathaway H, Kosciolek T, Knight R, et al
    Gut microbiome in serious mental illnesses: A systematic review and critical evaluation.
    Schizophr Res. 2021;234:24-40.
    PubMed     Abstract available

    July 2021
  281. DEL RE EC, Tan EJ
    Let's talk about researchers: A SIRS roundtable on mental health among schizophrenia researchers.
    Schizophr Res. 2021;235:63-64.

  282. IRURETAGOYENA B, Castaneda CP, Mena C, Diaz C, et al
    Predictors of clozapine discontinuation at 2years in treatment-resistant schizophrenia.
    Schizophr Res. 2021;235:102-108.
    PubMed     Abstract available

  283. MACDONALD KI, Spilka MJ, Bartolomeo LA, Raugh IM, et al
    Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis.
    Schizophr Res. 2021 Jul 29. pii: S0920-9964(21)00283.

  284. HALVERSON TF, Meyer-Kalos PS, Perkins DO, Gaylord SA, et al
    Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT).
    Schizophr Res. 2021;235:91-101.
    PubMed     Abstract available

  285. LINKE M, Jankowski KS
    Chronotype in individuals with schizophrenia: A meta-analysis.
    Schizophr Res. 2021;235:74-79.
    PubMed     Abstract available

  286. SANTO-ANGLES A, Salvador R, Gomar JJ, Guerrero-Pedraza A, et al
    Interindividual variability of functional connectome in schizophrenia.
    Schizophr Res. 2021;235:65-73.
    PubMed     Abstract available

  287. GROVER S, Keshavan MS, Lizano PL, Reinhart RMG, et al
    Proximate markers of cognitive dysfunction in schizophrenia.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00272.

  288. HANSEN MC, Lynch DA, Stefancic A, Medalia A, et al
    Metamotivation in people diagnosed with schizophrenia: A conceptual introduction and qualitative study.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00215.
    PubMed     Abstract available

  289. PRASAD KM
    Infectious agents as risk factors for psychosis - A time to reconsider and reinvigorate investigations.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00259.

  290. WANG YC, Chen CH, Chen SJ, Cheng FY, et al
    Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing.
    Schizophr Res. 2021;235:60-62.

  291. HIGUCHI CH, Cogo-Moreira H, Fonseca L, Ortiz BB, et al
    Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging.
    Schizophr Res. 2021 Jul 22. pii: S0920-9964(21)00249.
    PubMed     Abstract available

  292. BULUBAS L, Goerigk S, Gomes JS, Brem AK, et al
    Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial.
    Schizophr Res. 2021;235:44-51.
    PubMed     Abstract available

  293. DLAGNEKOVA A, van Staden W, Masenge A
    Validity and reliability of the Vigour Assessment Scale in avolitional schizophrenia outpatients.
    Schizophr Res. 2021;235:36-43.
    PubMed     Abstract available

  294. GROVER S, Naskar C, Sahoo S, Mehra A, et al
    Starting clozapine in patients with schizophrenia during the ongoing pandemic.
    Schizophr Res. 2021 Jul 21. pii: S0920-9964(21)00257.

  295. STROMME MF, Mellesdal LS, Bartz-Johannesen C, Kroken RA, et al
    Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study.
    Schizophr Res. 2021;235:29-35.
    PubMed     Abstract available

  296. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: Findings of dose-response analysis from a pilot randomized controlled trial.
    Schizophr Res. 2021 Jul 20. pii: S0920-9964(21)00268.

  297. TENDILLA-BELTRAN H, Coatl-Cuaya H, Meneses-Prado S, Vazquez-Roque RA, et al
    Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats.
    Schizophr Res. 2021;235:17-28.
    PubMed     Abstract available

  298. ZHAO Y, Wen SW, Qin Y, Liu Y, et al
    Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism.
    Schizophr Res. 2021;235:12-16.
    PubMed     Abstract available

  299. YANG K, Hua J, Etyemez S, Paez A, et al
    Volumetric alteration of olfactory bulb and immune-related molecular changes in olfactory epithelium in first episode psychosis patients.
    Schizophr Res. 2021;235:9-11.

  300. CARRION RE, Auther AM, McLaughlin D, Cornblatt BA, et al
    The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study.
    Schizophr Res. 2021;236:9-11.

  301. KREIS I, Zhang L, Moritz S, Pfuhl G, et al
    Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00246.
    PubMed     Abstract available

  302. KOHLER-FORSBERG O, Madsen T, Behrendt-Moller I, Nordentoft M, et al
    The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00245.
    PubMed     Abstract available

  303. YOON JH, Maddock RJ, Laufer J, Minzenberg MJ, et al
    Absence of altered in vivo concentration of dorsolateral prefrontal cortex GABA in recent onset schizophrenia.
    Schizophr Res. 2021 Jul 9. pii: S0920-9964(21)00230.

  304. BROWNE J, Mohamed S
    Evaluation of disparities in impact of mental health intensive case management on 6-month symptoms, functioning, and quality of life between black and white veterans diagnosed with schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00255.
    PubMed     Abstract available

  305. ALBINANA C, Boelt SG, Cohen AS, Zhu Z, et al
    Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00216.
    PubMed     Abstract available

  306. XI YB, Guo F, Liu WM, Fu YF, et al
    Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging.
    Schizophr Res. 2021;233:89-96.
    PubMed     Abstract available

  307. DE CATES AN, Catone G, Marwaha S, Bebbington P, et al
    Self-harm, suicidal ideation, and the positive symptoms of psychosis: Cross-sectional and prospective data from a national household survey.
    Schizophr Res. 2021;233:80-88.
    PubMed     Abstract available

  308. KHACHADOURIAN V, Zaks N, Lin E, Reichenberg A, et al
    Advanced paternal age and risk of schizophrenia in offspring - Review of epidemiological findings and potential mechanisms.
    Schizophr Res. 2021;233:72-79.
    PubMed     Abstract available

  309. POOLE-WRIGHT K, Gaughran F, Murray R, Chalder T, et al
    Fatigue in psychosis.
    Schizophr Res. 2021 Jul 6. pii: S0920-9964(21)00244.

  310. GROSSMAN MJ, Bowie CR
    Money talks: The influence of extrinsic motivators on social cognition in early episode psychosis.
    Schizophr Res. 2021;233:52-59.
    PubMed     Abstract available

  311. HOY KE, Coyle H, Gainsford K, Hill AT, et al
    Investigating neurophysiological markers of impaired cognition in schizophrenia.
    Schizophr Res. 2021;233:34-43.
    PubMed     Abstract available

  312. O'DONOGHUE B, Castagnini E, Langstone A, Mifsud N, et al
    Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.
    Schizophr Res. 2021;233:31-33.

  313. BURKHARDT E, Berger M, Yolken RH, Lin A, et al
    Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Schizophr Res. 2021;233:24-30.
    PubMed     Abstract available

  314. SALGADO-PINEDA P, Fuentes-Claramonte P, Spanlang B, Pomes A, et al
    Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the 'enfacement' paradigm.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00243.
    PubMed     Abstract available

  315. IGATA R, Tesen H, Konishi Y, Ikenouchi A, et al
    Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00253.

  316. BRAR PS, Sass L, Kalarchian MA
    Advancing research on delusions: Fostering dialogue between cognitive and phenomenological researchers.
    Schizophr Res. 2021;233:62-63.

    June 2021
  317. XIE Y, Xi Y, Cui LB, Li C, et al
    Altered functional connectivity of the dentate nuclei in patients with schizophrenia.
    Schizophr Res. 2021;233:16-23.
    PubMed     Abstract available

  318. BONFILS KA, Luther L, Lysaker PH
    Metacognition & social cognition differentially influence experiential & expressive negative symptoms in schizophrenia.
    Schizophr Res. 2021;233:13-15.

  319. FUSAR-POLI P, Salazar de Pablo G
    Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00242.

  320. BANEA OC, Bandeira Dos Santos LG, Marcu S, Stefannson SB, et al
    Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00214.

  321. GAO Y, Li M, Huang AS, Anderson AW, et al
    Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia.
    Schizophr Res. 2021 Jun 29. pii: S0920-9964(21)00225.
    PubMed     Abstract available

  322. HU M, Qian X, Liu S, Koh AJ, et al
    Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks.
    Schizophr Res. 2021 Jun 28. pii: S0920-9964(21)00223.
    PubMed     Abstract available

  323. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
    Association of g-quadruplex variants with schizophrenia symptoms.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00220.

  324. HU Y, Xu L, Gan R, Wu G, et al
    A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00240.
    PubMed     Abstract available

  325. CLAYSON PE, Joshi YB, Thomas ML, Tarasenko M, et al
    The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00234.
    PubMed     Abstract available

  326. RUBIO JM, Lencz T, Barber A, Moyett A, et al
    Striatal functional connectivity in psychosis relapse: A hypothesis generating study.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00222.
    PubMed     Abstract available

  327. BARLATI S, Morena D, Nibbio G, Cacciani P, et al
    Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00219.
    PubMed     Abstract available

  328. KRONICK J, Sabesan P, Burhan AM, Palaniyappan L, et al
    Assessment of treatment resistance criteria in non-invasive brain stimulation studies of schizophrenia.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00221.
    PubMed     Abstract available

  329. YESILKAYA UH, Sen M, Karamustafalioglu N
    New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus.
    Schizophr Res. 2021 Jun 16. pii: S0920-9964(21)00213.

  330. METZAK PD, Farris MS, Placsko T, Braun A, et al
    Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.
    Schizophr Res. 2021;233:3-12.
    PubMed     Abstract available

  331. CORTES-BRIONES JA, Tapia-Rivas NI, D'Souza DC, Estevez PA, et al
    Going deep into schizophrenia with artificial intelligence.
    Schizophr Res. 2021 Jun 5. pii: S0920-9964(21)00179.
    PubMed     Abstract available

  332. BOMMERSBACH TJ, Rhee TG, Stefanovics EA, Rosenheck RA, et al
    Comparison of Black and white individuals who report diagnoses of schizophrenia in a national sample of US adults: Discrimination and service use.
    Schizophr Res. 2021 Jun 1. pii: S0920-9964(21)00178.
    PubMed     Abstract available

    May 2021
  333. LISOWAY AJ, Chen CC, Zai CC, Tiwari AK, et al
    Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment.
    Schizophr Res. 2021;232:112-124.
    PubMed     Abstract available

  334. ZHANG YJ, Pu CC, Wang YM, Zhang RT, et al
    Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia.
    Schizophr Res. 2021;232:77-84.
    PubMed     Abstract available

  335. SENGUTTA M, Karow A, Moritz S
    Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses.
    Schizophr Res. 2021;232:107-108.

  336. FORTEA A, Batalla A, Radua J, van Eijndhoven P, et al
    Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis.
    Schizophr Res. 2021;232:98-106.
    PubMed     Abstract available

  337. WANG D, Zhuo K, Sun Y, Xiang Q, et al
    Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naive first-episode psychosis patients: A pilot longitudinal study.
    Schizophr Res. 2021;232:95-97.

  338. HEGELSTAD WTV, Berg AO, Bjornestad J, Gismervik K, et al
    Childhood interpersonal trauma and premorbid social adjustment as predictors of symptom remission in first episode psychosis.
    Schizophr Res. 2021;232:87-94.
    PubMed     Abstract available

  339. WELLESLEY WESLEY E, Patel I, Kadra-Scalzo G, Pritchard M, et al
    Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register.
    Schizophr Res. 2021;232:68-76.
    PubMed     Abstract available

  340. MOXAM AB, McClellan EJ, Cagande C, Calkins ME, et al
    Few primary care pediatricians screen for psychosis but many are willing.
    Schizophr Res. 2021;232:65-67.

    Prenatal infection and schizophrenia: A decade of further progress.
    Schizophr Res. 2021 May 17. pii: S0920-9964(21)00174.
    PubMed     Abstract available

  342. DEL RE EC
    The 2020 World Congress of Psychiatric Genetics: Schizophrenia highlights with an eye on sex differences.
    Schizophr Res. 2021;232:63-64.

  343. BARTOLI F, Cioni RM, Callovini T, Cavaleri D, et al
    The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
    Schizophr Res. 2021;232:61-62.

  344. TARGUM SD, Pendergrass JC, Murphy C
    Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.
    Schizophr Res. 2021;232:54-60.
    PubMed     Abstract available

  345. KAHN RS, Silverman BL, DiPetrillo L, Graham C, et al
    A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
    Schizophr Res. 2021;232:45-53.
    PubMed     Abstract available

  346. TIIHONEN J, Koskuvi M, Lahteenvuo M, Trontti K, et al
    Molecular signaling pathways underlying schizophrenia.
    Schizophr Res. 2021;232:33-41.
    PubMed     Abstract available

  347. SEVERANCE EG, Yolken RH
    Binning bugs and beyond: The state of the schizophrenia microbiome.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00162.

  348. VANES LD, Murray RM, Nosarti C
    Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00152.
    PubMed     Abstract available

  349. SARRE A, Abdel-Ahad P, Meilland A, Renard U, et al
    Verbal hallucinations in deaf schizophrenia patients.
    Schizophr Res. 2021;232:31-32.

  350. MAYORAL-VAN SON J, Juncal-Ruiz M, Ortiz-Garcia de la Foz V, Vazquez-Bourgon J, et al
    Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort.
    Schizophr Res. 2021;232:28-30.

  351. WRIGHT AC, Browne J, Skiest H, Bhiku K, et al
    The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2021;232:11-27.
    PubMed     Abstract available

  352. GEBICKE-HAERTER PJ, Leonardi-Essmann F, Haerter JO, Rossner MJ, et al
    Differential gene regulation in the anterior cingulate cortex and superior temporal cortex in schizophrenia: A molecular network approach.
    Schizophr Res. 2021;232:1-10.
    PubMed     Abstract available

  353. NASKAR C
    Understanding the effect of various factors on clozapine serum levels in Indian population.
    Schizophr Res. 2021;231:178.

  354. OREPIC P, Rognini G, Kannape OA, Faivre N, et al
    Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners.
    Schizophr Res. 2021;231:170-177.
    PubMed     Abstract available

  355. MISAWA F, Okumura Y, Takeuchi Y, Fujii Y, et al
    Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
    Schizophr Res. 2021;231:42-46.
    PubMed     Abstract available

    April 2021
  356. KIDD SA, Mutschler C, Lichtenstein S, Yan S, et al
    Randomized trial of a brief peer support intervention for individuals with schizophrenia transitioning from hospital to community.
    Schizophr Res. 2021;231:214-220.
    PubMed     Abstract available

  357. RUNGE K, Fiebich BL, Kuzior H, Saliba SW, et al
    An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders.
    Schizophr Res. 2021;231:205-213.
    PubMed     Abstract available

  358. TEEUW J, Ori APS, Brouwer RM, de Zwarte SMC, et al
    Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia.
    Schizophr Res. 2021;231:189-197.
    PubMed     Abstract available

  359. WANG C, Oughourlian T, Tishler TA, Anwar F, et al
    Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia.
    Schizophr Res. 2021;231:179-188.
    PubMed     Abstract available

  360. BROWNE J, Wright AC, Berry K, Mueser KT, et al
    The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis.
    Schizophr Res. 2021;231:154-163.
    PubMed     Abstract available

  361. MEKORI-DOMACHEVSKY E, Taler M, Weinberger R, Guri Y, et al
    Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
    Schizophr Res. 2021;231:164-169.
    PubMed     Abstract available

  362. PINHO S, Rocha V, Vieira-Coelho MA
    Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review.
    Schizophr Res. 2021;231:145-153.
    PubMed     Abstract available

  363. DICKERSON F, Origoni A, Katsafanas E, Squire A, et al
    Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia.
    Schizophr Res. 2021;231:142-144.

  364. HOGERZEIL SJ, Hoek HW, van Hemert AM
    The impact of study design on schizophrenia incidence estimates: A systematic review of Northern European studies 2008-2019.
    Schizophr Res. 2021;231:134-141.
    PubMed     Abstract available

  365. AJNAKINA O, Stubbs B, Francis E, Gaughran F, et al
    Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies.
    Schizophr Res. 2021;231:122-133.
    PubMed     Abstract available

  366. FRAGUAS D, Diaz-Caneja CM, Pina-Camacho L, Winter van Rossum I, et al
    The role of depression in the prediction of a "late" remission in first-episode psychosis: An analysis of the OPTiMiSE study.
    Schizophr Res. 2021;231:100-107.
    PubMed     Abstract available

  367. TAO B, Xiao Y, Yang B, Zeng J, et al
    Morphological alterations of the corpus callosum in antipsychotic-naive first-episode schizophrenia before and 1-year after treatment.
    Schizophr Res. 2021;231:115-121.
    PubMed     Abstract available

  368. FREEDMAN R, Hunter SK, Law AJ, Clark AM, et al
    Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum.
    Schizophr Res. 2021 Apr 7. pii: S0920-9964(21)00128.
    PubMed     Abstract available

  369. GIBBONS RD, Chattopadhyay I, Meltzer H, Kane JM, et al
    Development of a computerized adaptive diagnostic screening tool for psychosis.
    Schizophr Res. 2021 Apr 6. pii: S0920-9964(21)00140.
    PubMed     Abstract available

  370. SOUSA AE, Ryan JD, Lepage M
    A feasibility pilot study on using unitization to circumvent relational memory impairments in schizophrenia.
    Schizophr Res. 2021;231:98-99.

  371. RAO NP, Ramachandran P, Jacob A, Joseph A, et al
    Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial.
    Schizophr Res. 2021;231:90-97.
    PubMed     Abstract available

  372. MAITRA R, Pollak TA, Pritchard M, Shergill S, et al
    Stem cell transplant in psychotic disorders: Immunological cause or cure?
    Schizophr Res. 2021;230:50-52.

    The only difference between a jail and a psychiatric hospital is a pillow.
    Schizophr Res. 2021;230:100.
    PubMed     Abstract available

    March 2021
  374. PRUESSNER M, King S, Veru F, Schalinski I, et al
    Impact of childhood trauma on positive and negative symptom remission in first episode psychosis.
    Schizophr Res. 2021;231:82-89.
    PubMed     Abstract available

  375. KOSHIYAMA D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, et al
    Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia.
    Schizophr Res. 2021;231:73-81.
    PubMed     Abstract available

  376. ADELINO MPM, Nunes MV, Nunes MFQ, Costa ER Jr, et al
    Treatment-resistant schizophrenia - A RCT on the effectiveness of repeated-dose sodium nitroprusside.
    Schizophr Res. 2021;231:70-72.
    PubMed     Abstract available

  377. YANG J, Kang C, Wu C, Lin Y, et al
    Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia.
    Schizophr Res. 2021;231:67-69.
    PubMed     Abstract available

  378. SAPERSTEIN AM, Choi CJ, Jahshan C, Lynch DA, et al
    Predicting response to cognitive training for schizophrenia using results from two studies with different outcomes.
    Schizophr Res. 2021;231:61-66.
    PubMed     Abstract available

  379. WOLF RC, Kubera KM, Waddington JL, Schmitgen MM, et al
    A neurodevelopmental signature of parkinsonism in schizophrenia.
    Schizophr Res. 2021;231:54-60.
    PubMed     Abstract available

  380. ZITO MF, Subotnik KL, Ventura J, Kern RS, et al
    Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia.
    Schizophr Res. 2021;231:51-53.

  381. SUHAS S
    COVID 19 vaccination of persons with schizophrenia in India - Need for imperative action!
    Schizophr Res. 2021;231:49-50.

  382. HUANG TY, Deng WF, Li XP, Chen HQ, et al
    Higher prevalence of coronary artery calcification in schizophrenia patients.
    Schizophr Res. 2021;231:47-48.

  383. HAINING K, Brunner G, Gajwani R, Gross J, et al
    The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach.
    Schizophr Res. 2021;231:24-31.
    PubMed     Abstract available

  384. SCHEFFLER F, Du Plessis S, Asmal L, Kilian S, et al
    Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls.
    Schizophr Res. 2021;231:13-21.
    PubMed     Abstract available

  385. DAMIANI S, Scalabrini A, Ku HL, Lane TJ, et al
    From local to global and back: An exploratory study on cross-scale desynchronization in schizophrenia and its relation to thought disorders.
    Schizophr Res. 2021;231:10-12.

  386. O'DONOGHUE B, Nelson B, Francey S, McGorry P, et al
    Response to 'Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis'.
    Schizophr Res. 2021;231:1-2.

  387. NASIB LG, Gangadin SS, Rossum IW, Boudewijns ZSRM, et al
    The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial.
    Schizophr Res. 2021;230:79-86.
    PubMed     Abstract available

  388. PURUSHOTHAMAN D, Jacob AA, Kumar V, Varambally S, et al
    The dilemma of self vs others' interest: Altruistic behaviour in schizophrenia and the role of vasopressin.
    Schizophr Res. 2021;230:77-78.

  389. PERRY BI, Zammit S, Jones PB, Khandaker GM, et al
    Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort.
    Schizophr Res. 2021;230:69-76.
    PubMed     Abstract available

  390. PAWELCZYK T, Grancow-Grabka M, Zurner N, Pawelczyk A, et al
    Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Schizophr Res. 2021;230:61-68.
    PubMed     Abstract available

  391. WANG DD, Hu XW, Jiang J, Sun LY, et al
    Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Schizophr Res. 2021;230:53-60.
    PubMed     Abstract available

  392. YAN W, Zhao M, Fu Z, Pearlson GD, et al
    Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: A deep classification and clustering framework using fMRI time series.
    Schizophr Res. 2021 Mar 3. pii: S0920-9964(21)00077.
    PubMed     Abstract available

  393. WANG J, Kochunov P, Sampath H, Hatch KS, et al
    White matter brain aging in relationship to schizophrenia and its cognitive deficit.
    Schizophr Res. 2021;230:9-16.
    PubMed     Abstract available

    Estimating the prevalence of schizophrenia in the United States using the multiplier method.
    Schizophr Res. 2021;230:48-49.

  395. TSANG A, Bucci S, Branitsky A, Kaptan S, et al
    The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review.
    Schizophr Res. 2021;230:38-47.
    PubMed     Abstract available

  396. JACOB MS, Roach BJ, Hamilton HK, Carrion RE, et al
    Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.
    Schizophr Res. 2021;230:26-37.
    PubMed     Abstract available

  397. CHUNG AK, Chan WM, Law JK, Tse CY, et al
    Ketamine abusers with SLC6A3 rs393795 genotype showed a preliminary association with psychosis and schizophrenia: A pilot case-control study.
    Schizophr Res. 2021;230:24-25.

  398. DURAND D, Strassnig MT, Moore RC, Depp CA, et al
    Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias.
    Schizophr Res. 2021;230:17-23.
    PubMed     Abstract available

  399. ENACHE D, Nikkheslat N, Fathalla D, Morgan BP, et al
    Peripheral immune markers and antipsychotic non-response in psychosis.
    Schizophr Res. 2021;230:1-8.
    PubMed     Abstract available

  400. YAEGASHI H, Misawa F, Noda H, Fujii Y, et al
    Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trials.
    Schizophr Res. 2021;229:94-101.
    PubMed     Abstract available

    February 2021
  401. SEVERANCE EG, Leister F, Lea A, Yang S, et al
    Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia.
    Schizophr Res. 2021 Feb 23. pii: S0920-9964(21)00071.
    PubMed     Abstract available

  402. SHAD MU
    Is high-dose maintenance therapy effective in treatment-refractory psychosis? A case series.
    Schizophr Res. 2021;229:38-42.

  403. JOHNSON KA, Guyer M, Ongur D, Friedman-Yakoobian M, et al
    Early intervention in psychosis: Building a strategic roadmap for Massachusetts.
    Schizophr Res. 2021;229:43-45.

  404. NOYAN H, Erdag E, Tuzun E, Yaylim I, et al
    Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1beta levels in patients with schizophrenia spectrum disorder and their siblings.
    Schizophr Res. 2021;229:27-37.
    PubMed     Abstract available

  405. SUHAS S, Kumar V, Venkatasubramanian G
    Therapeutic drug monitoring of clozapine in Indian patients with schizophrenia - Authors response.
    Schizophr Res. 2021;229:25-26.

  406. MEHTA UM, Keshavan MS
    Hindsight 2020: Emerging research trends in schizophrenia.
    Schizophr Res. 2021;229:22-24.

  407. PARIS G, Bighelli I, Deste G, Siafis S, et al
    Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis.
    Schizophr Res. 2021;229:3-11.
    PubMed     Abstract available

  408. HANLON FM, Dodd AB, Ling JM, Shaff NA, et al
    The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum.
    Schizophr Res. 2021;229:12-21.
    PubMed     Abstract available

  409. MC GLANAGHY E, Turner D, Davis GA, Sharpe H, et al
    A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms.
    Schizophr Res. 2021;228:447-459.
    PubMed     Abstract available

  410. KULKARNI G, Mehta UM, Das S, Arunachal G, et al
    Novel CTSF Indel in a patient with Kufs disease and resistant schizophrenia: A case report.
    Schizophr Res. 2021;228:435-437.

  411. GAIGL G, Taumer E, Merz K, Zoscher S, et al
    Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.
    Schizophr Res. 2021;228:425-434.
    PubMed     Abstract available

  412. OH J, Nam H, Park S, Chae JH, et al
    Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study.
    Schizophr Res. 2021;228:417-424.
    PubMed     Abstract available

  413. PUNTIS S, Oliver D, Fusar-Poli P
    Third external replication of an individualised transdiagnostic prediction model for the automatic detection of individuals at risk of psychosis using electronic health records.
    Schizophr Res. 2021;228:403-409.
    PubMed     Abstract available

  414. DAR S, Liebenthal E, Pan H, Smith T, et al
    Abnormal semantic processing of threat words associated with excitement and hostility symptoms in schizophrenia.
    Schizophr Res. 2021;228:394-402.
    PubMed     Abstract available

  415. HIGGINS A, Lewandowski KE, Liukasemsarn S, Hall MH, et al
    Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.
    Schizophr Res. 2021;228:385-393.
    PubMed     Abstract available

  416. HERNIMAN SE, Cotton SM, Allott KA, Phillips LJ, et al
    The psychometric validity of the Montgomery-Asberg Depression Rating Scale (MADRS) in recent onset schizophrenia spectrum disorders.
    Schizophr Res. 2021;228:373-381.
    PubMed     Abstract available

  417. DUFVA YE, Westman H, Khilbom U, Sullivan PF, et al
    Swedish large-scale schizophrenia study: Why do patients and healthy controls participate?
    Schizophr Res. 2021;228:360-366.
    PubMed     Abstract available

  418. DIAZ-CUTRARO L, Garcia-Mieres H, Lopez-Carrilero R, Ferrer M, et al
    Jumping to conclusions is differently associated with specific subtypes of delusional experiences: An exploratory study in first-episode psychosis.
    Schizophr Res. 2021;228:357-359.

  419. MCGORRY PD, Mei C, Hartmann J, Yung AR, et al
    Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis.
    Schizophr Res. 2021;228:344-356.
    PubMed     Abstract available

  420. BERRY C, Newcombe H, Strauss C, Rammou A, et al
    Validation of the Hamilton Program for Schizophrenia Voices Questionnaire: Associations with emotional distress and wellbeing, and invariance across diagnosis and sex.
    Schizophr Res. 2021;228:336-343.
    PubMed     Abstract available

  421. VER LOREN VAN THEMAAT AH, Hemager N, Korsgaard Johnsen L, Klee Burton B, et al
    Development of visual attention from age 7 to age 12 in children with familial high risk for schizophrenia or bipolar disorder.
    Schizophr Res. 2021;228:327-335.
    PubMed     Abstract available

  422. KEEFE RSE
    Where do we cut the bell-shaped curve of CIAS?
    Schizophr Res. 2021;228:633-634.

  423. KOLBAEK P, Dines D, Hansen J, Opler M, et al
    Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).
    Schizophr Res. 2021;228:438-446.
    PubMed     Abstract available

  424. LAHTEENVUO M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, et al
    Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.
    Schizophr Res. 2021;228:367-372.
    PubMed     Abstract available

  425. DAS D, Peng X, Lam AN, Bader JS, et al
    Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis.
    Schizophr Res. 2021;228:324-326.
    PubMed     Abstract available

  426. SUMNER PJ, Rossell SL, Tan EJ
    On the assessment of subjective formal thought disorder.
    Schizophr Res. 2021;228:58-59.

  427. SUHAS S, Nagpal M, Rao NP, Kumar V, et al
    Echo of reading - The forgotten psychopathology: A case report.
    Schizophr Res. 2021;228:602-603.

  428. RABINOWITZ J, Opler M, Rabinowitz AA, Negash S, et al
    Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP).
    Schizophr Res. 2021;228:529-533.
    PubMed     Abstract available

    January 2021
  429. MOYA LACASA C, Rayner T, Hagen MM, Yang W, et al
    Anti-cyomegalovirus antibodies in schizophrenia and related disorders: A systematic review and meta-analysis.
    Schizophr Res. 2021;228:322-323.

  430. BOLBECKER AR, Apthorp D, Bartolomeo LA, O'Donnell BF, et al
    Postural sway in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2021;228:319-321.

  431. LAVEBRATT C, Stiernborg M, Kumar P, Yacaman-Mendez D, et al
    Physical exercise is associated with a reduction in inflammatory biomarkers in first-episode psychosis: A pilot study of CRP, SAA, sICAM-1 and sVCAM-1.
    Schizophr Res. 2021;228:316-318.

  432. KALINKOVICH A, Pouyrovsky M, Nasyrova R, Livshits G, et al
    Biased activation of inflammation pro-resolving receptors as an evolving supportive strategy in schizophrenia treatment.
    Schizophr Res. 2021;228:295-297.

  433. MEHTA UM, Naik SS, Thirthalli J
    Global visuospatial processing - a screening tool to predict cognition in schizophrenia.
    Schizophr Res. 2021;228:311-313.

  434. BORNHEIMER LA, Wojtalik JA, Li J, Cobia D, et al
    Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.
    Schizophr Res. 2021;228:298-304.
    PubMed     Abstract available

  435. CHAN SKW, Liu T, Wong AOY, Wong GHY, et al
    Self-referential gaze perception of patients with schizophrenia and its relationship with symptomatology and cognitive functions.
    Schizophr Res. 2021;228:288-294.
    PubMed     Abstract available

  436. KOSHIYAMA D, Miyakoshi M, Thomas ML, Joshi YB, et al
    Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
    Schizophr Res. 2021;228:280-287.
    PubMed     Abstract available

  437. HARE SM, Adhikari BM, Du X, Garcia L, et al
    Local versus long-range connectivity patterns of auditory disturbance in schizophrenia.
    Schizophr Res. 2021;228:262-270.
    PubMed     Abstract available

  438. GRIFFITHS SL, Wood SJ, Fowler D, Freemantle N, et al
    Improved social functioning following social recovery therapy in first episode psychosis: Do social cognition and neurocognition change following therapy, and do they predict treatment response?
    Schizophr Res. 2021;228:249-255.
    PubMed     Abstract available

  439. ZENG J, Zhang W, Xiao Y, Fu G, et al
    Pretreatment abnormalities in white matter integrity predict one-year clinical outcome in first episode schizophrenia.
    Schizophr Res. 2021;228:241-248.
    PubMed     Abstract available

    The risk for Torsades de Pointes and polypharmacy in schizophrenia.
    Schizophr Res. 2021;228:239-240.

  441. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Iliadou V, et al
    Could early diagnosis and rehabilitation of Auditory Processing Disorder in schizophrenia have a positive effect on cognition?
    Schizophr Res. 2021;228:237-238.

  442. BRUINS J, Pijnenborg GHM, Wunderink L, Visser E, et al
    The association of cannabis use with quality of life and psychosocial functioning in psychosis.
    Schizophr Res. 2021;228:229-234.
    PubMed     Abstract available

  443. CAMPANA M, Falkai P, Siskind D, Hasan A, et al
    Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;228:218-226.
    PubMed     Abstract available

  444. DICKERSON F, Katsafanas E, Origoni A, Squire A, et al
    Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.
    Schizophr Res. 2021;228:193-197.
    PubMed     Abstract available

  445. BIGSETH TT, Fredriksen M, Egeland J, Andersen E, et al
    Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study.
    Schizophr Res. 2021;228:190-192.

  446. CORRELL CU, Vanover KE, Davis RE, Chen R, et al
    Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia.
    Schizophr Res. 2021;228:198-205.
    PubMed     Abstract available

  447. ADDINGTON J, Santesteban-Echarri O, Braun A, Lecomte T, et al
    Assessing social functioning in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;228:188-189.

  448. SZESZKO PR, McNamara RK, Gallego JA, Malhotra AK, et al
    Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.
    Schizophr Res. 2021;228:180-187.
    PubMed     Abstract available

  449. ALLE MC, Berna F, Danion JM, Berntsen D, et al
    Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories.
    Schizophr Res. 2021;228:89-96.
    PubMed     Abstract available

  450. POPE LG, Manseau MW, Kelley ME, Compton MT, et al
    Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization.
    Schizophr Res. 2021;228:83-88.
    PubMed     Abstract available

  451. SCHOONOVER KE, Farmer CB, Morgan CJ, Sinha V, et al
    Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.
    Schizophr Res. 2021;228:60-73.
    PubMed     Abstract available

  452. MUKKU SSR, Nadella RK, Sivakumar PT, Sinha P, et al
    Is late onset schizophrenia a forerunner of Frontotemporal dementia? - A case series.
    Schizophr Res. 2021;228:56-57.

  453. PENNEY D, El-Baalbaki G, Lepage M
    Prevalence and severity of posttraumatic stress symptoms in psychosis: Associations with affective and patient-centered variables in those referred for psychological services.
    Schizophr Res. 2021;228:53-55.

  454. ABPLANALP SJ, Gold A, Gonzalez R, Doshi S, et al
    Feasibility of using smartphones to capture speech during social interactions in schizophrenia.
    Schizophr Res. 2021;228:51-52.

  455. LINCOLN SH, Johnson T, Winters A, Laquidara J, et al
    Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research.
    Schizophr Res. 2021;228:43-50.
    PubMed     Abstract available

  456. SPARK J, Gaweda L, Allott K, Hartmann JA, et al
    Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition.
    Schizophr Res. 2021;228:19-28.
    PubMed     Abstract available

  457. VILA-BADIA R, Butjosa A, Del Cacho N, Serra-Arumi C, et al
    Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psychosis? A systematic review.
    Schizophr Res. 2021;228:159-179.
    PubMed     Abstract available

  458. BOGE K, Hahne I, Bergmann N, Wingenfeld K, et al
    Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
    Schizophr Res. 2021;228:134-144.
    PubMed     Abstract available

  459. SCHOONOVER KE, Roberts RC
    Markers of copper transport in the cingulum bundle in schizophrenia.
    Schizophr Res. 2021;228:124-133.
    PubMed     Abstract available

  460. HEDBERG M, Imbeault S, Erhardt S, Schwieler L, et al
    Disrupted sensorimotor gating in first-episode psychosis patients is not affected by short-term antipsychotic treatment.
    Schizophr Res. 2021;228:118-123.
    PubMed     Abstract available

  461. SENDI MSE, Pearlson GD, Mathalon DH, Ford JM, et al
    Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia.
    Schizophr Res. 2021;228:103-111.
    PubMed     Abstract available

  462. ZHANG Y, Geyfman A, Coffman B, Gill K, et al
    Distinct alterations in resting-state electroencephalogram during eyes closed and eyes open and between morning and evening are present in first-episode psychosis patients.
    Schizophr Res. 2021;228:36-42.
    PubMed     Abstract available

  463. SMESNY S, Berberich D, Gussew A, Schonfeld N, et al
    Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up (1)H/(31)P-MR-spectroscopy study.
    Schizophr Res. 2021;228:7-18.
    PubMed     Abstract available

  464. SECCOMANDI B, Agbedjro D, Bell M, Keefe RSE, et al
    Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia.
    Schizophr Res. 2021;228:29-35.
    PubMed     Abstract available

  465. KIMURA M, Oda Y, Oishi K, Yoshino K, et al
    Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Schizophr Res. 2021;228:1-6.
    PubMed     Abstract available

  466. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;227:63-71.
    PubMed     Abstract available

  467. MALHI GS, Bell E, Hamilton A, Morris G, et al
    Early intervention for risk syndromes: What are the real risks?
    Schizophr Res. 2021;227:4-9.

    December 2020
  468. ELLERSGAARD D, Gregersen M, Spang KS, Christiani C, et al
    Psychotic experiences in seven-year-old children with familial high risk of schizophrenia or bipolar disorder in: The Danish High Risk and Resilience Study - VIA 7; A population-based cohort study.
    Schizophr Res. 2020 Dec 9. pii: S0920-9964(20)30589.
    PubMed     Abstract available

  469. BOUET V, Percelay S, Leroux E, Diarra B, et al
    A new 3-hit mouse model of schizophrenia built on genetic, early and late factors.
    Schizophr Res. 2020 Dec 7. pii: S0920-9964(20)30583.
    PubMed     Abstract available

  470. MITTAL VA, Addington JM
    Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis.
    Schizophr Res. 2020 Dec 4. pii: S0920-9964(20)30554.

  471. LI X, Guo X, Fan X, Feng T, et al
    Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30529.
    PubMed     Abstract available

  472. WUNDERINK L, van Bebber J, Sytema S, Boonstra N, et al
    Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30590.
    PubMed     Abstract available

  473. YEE CI, Vargas T, Mittal VA, Haase CM, et al
    Adaptability and cohesion in youth at clinical high-risk for psychosis: A multi-informant approach.
    Schizophr Res. 2020 Dec 1. pii: S0920-9964(20)30579.
    PubMed     Abstract available

    November 2020
  474. JABAR LSA, Sorensen HJ, Nordentoft M, Hjorthoj C, et al
    Associations between duration of untreated psychosis and domains of positive and negative symptoms persist after 10 years of follow-up: A secondary analysis from the OPUS trial.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30567.
    PubMed     Abstract available

  475. KONSZTOWICZ S, Gelencser CR, Otis C, Schmitz N, et al
    Self-concept and Engagement in LiFe (SELF): A waitlist-controlled pilot study of a novel psychological intervention to target illness engulfment in enduring schizophrenia and related psychoses.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30568.
    PubMed     Abstract available

  476. PIERRE JM
    Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis.
    Schizophr Res. 2020 Nov 27. pii: S0920-9964(20)30582.

  477. BERENDSEN S, Kapitein P, Schirmbeck F, van Tricht MJ, et al
    Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30429.

  478. DIJKSTRA AA, Gami-Patel P, Rozemuller AJM, Bugiani M, et al
    Reduction of GABA subunit theta-containing cortical neurons in schizophrenia.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30577.

  479. CADENHEAD KS, Stone WS
    Commentary: Special issue on "Biomarkers in the attenuated psychosis syndrome".
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30575.

  480. ZHANG H, Wang D, Chen J, Wang Y, et al
    Rare variations in the SHANK3 gene confers susceptibility to schizophrenia in Uygur Chinese population.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30576.

  481. SCHULTZE-LUTTER F, Schimmelmann BG, Michel C
    Clinical high-risk of and conversion to psychosis in the community: A 3-year follow-up of a cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30572.

  482. LAWRENCE RE, Appelbaum PS, Lieberman JA
    A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30562.
    PubMed     Abstract available

  483. SEMENNOV IV, Zhilyaeva TV, Kasyanov ED, Mishanov GA, et al
    Association of tetrahydrobiopterin deficiency with disturbances in one-carbon metabolism in patients with schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30563.

  484. FUSAR-POLI P, Oliver D, Spada G, Estrade A, et al
    The case for improved transdiagnostic detection of first-episode psychosis: Electronic health record cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30571.
    PubMed     Abstract available

  485. PARLAR ME, Heinrichs RW
    Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30560.
    PubMed     Abstract available

  486. ZOPF R, Boulton K, Langdon R, Rich AN, et al
    Perception of visual-tactile asynchrony, bodily perceptual aberrations, and bodily illusions in schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30578.
    PubMed     Abstract available

  487. NASLUND JA, Hswen Y
    Person-based machine learning: Accounting for patient experience to explain the nature of schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30569.

  488. BITSCH F, Berger P, Nagels A, Falkenberg I, et al
    Characterizing the theory of mind network in schizophrenia reveals a sparser network structure.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30566.
    PubMed     Abstract available

  489. FUJIKAWA R, Yamada J, Jinno S
    Subclass imbalance of parvalbumin-expressing GABAergic neurons in the hippocampus of a mouse ketamine model for schizophrenia, with reference to perineuronal nets.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30555.
    PubMed     Abstract available

  490. TSO IF, Angstadt M, Rutherford S, Peltier S, et al
    Dynamic causal modeling of eye gaze processing in schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30551.
    PubMed     Abstract available

  491. FERNANDEZ-LINSENBARTH I, Planchuelo-Gomez A, Diez A, Arjona-Valladares A, et al
    Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30552.
    PubMed     Abstract available

  492. REFISCH A, Chung HY, Komatsuzaki S, Schumann A, et al
    A common variation in HCN1 is associated with heart rate variability in schizophrenia.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30556.
    PubMed     Abstract available

  493. ZHANG X, Liu W, Guo F, Li C, et al
    Disrupted structural covariance network in first episode schizophrenia patients: Evidence from a large sample MRI-based morphometric study.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30501.
    PubMed     Abstract available

  494. GAEBEL W, Stricker J, Hasan A, Falkai P, et al
    The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30530.

  495. HAARSMA J, Kok P, Browning M
    The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30496.
    PubMed     Abstract available

  496. SANDSTEN KE, Parnas J
    Altered self-recognition in schizophrenia - A reply to critics.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30494.

  497. LAGAN S, Camacho E, Torous J
    Is there a clinically relevant, publicly accessible app for that? Exploring the clinical relevance and availability of mobile apps for schizophrenia and psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30525.

  498. INTSON K, Geissah S, McCullumsmith RE, Ramsey AJ, et al
    A role for endothelial NMDA receptors in the pathophysiology of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30491.
    PubMed     Abstract available

  499. GREENWOOD TA, Swerdlow NR, Sprock J, Calkins ME, et al
    Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30500.
    PubMed     Abstract available

  500. MALASPINA D, Gonen O, Rhodes H, Hoffman KW, et al
    Hippocampal metabolite concentrations in schizophrenia vary in association with rare gene variants in the TRIO gene.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30498.

  501. PATEL RS, Sreeram V, Vadukapuram R, Baweja R, et al
    Do cannabis use disorders increase medication non-compliance in schizophrenia?: United States Nationwide inpatient cross-sectional study.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30499.
    PubMed     Abstract available

    October 2020
  502. JUTLA A, Califano A, Dishy G, Hesson H, et al
    Neurodevelopmental predictors of conversion to schizophrenia and other psychotic disorders in adolescence and young adulthood in clinical high risk individuals.
    Schizophr Res. 2020 Oct 31. pii: S0920-9964(20)30495.

  503. CARRION RE, Auther AM, McLaughlin D, Addington J, et al
    Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
    Schizophr Res. 2020 Oct 30. pii: S0920-9964(20)30464.
    PubMed     Abstract available

  504. YU L, Fang X, Chen Y, Wang Y, et al
    Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2020 Oct 28. pii: S0920-9964(20)30493.
    PubMed     Abstract available

  505. NAGENDRA A, Halverson TF, Pinkham AE, Harvey PD, et al
    Neighborhood socioeconomic status and racial disparities in schizophrenia: An exploration of domains of functioning.
    Schizophr Res. 2020 Oct 24. pii: S0920-9964(20)30478.
    PubMed     Abstract available

  506. SKLAR AL, Coffman BA, Haas G, Ghuman A, et al
    Inefficient visual search strategies in the first-episode schizophrenia spectrum.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30473.
    PubMed     Abstract available

  507. PEREZ MM, Tercero BA, Penn DL, Pinkham AE, et al
    Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30492.
    PubMed     Abstract available

  508. RAPADO-CASTRO M, Whittle S, Pantelis C, Thompson A, et al
    Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk?
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30475.
    PubMed     Abstract available

  509. GOLDRING A, Borne S, Hefner A, Thanju A, et al
    The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30436.
    PubMed     Abstract available

  510. EGERTON A, Grace AA, Stone J, Bossong MG, et al
    Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30471.
    PubMed     Abstract available

  511. SPENCER HM, Dudley R, Freeston MH, Turkington D, et al
    What are the essential ingredients of a CBT case conceptualization for voices and delusions in schizophrenia spectrum disorders? A study of expert consensus.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30484.
    PubMed     Abstract available

  512. BHATTACHARYYA S, Schoeler T, Patel R, di Forti M, et al
    Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30474.
    PubMed     Abstract available

  513. FRITZE S, Thieme CE, Kubera KM, Northoff G, et al
    Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30483.
    PubMed     Abstract available

  514. WHITTON AE, Merchant JT, Lewandowski KE
    Dissociable mechanisms underpinning effort-cost decision-making across the psychosis spectrum.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30472.
    PubMed     Abstract available

  515. MISHRA R, Mathur R, Verma R
    Altered self-recognition in schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30469.

  516. TERNOVOY S, Ustyuzhanin D, Morozova Y, Shariya M, et al
    Functional MRI evince the safety and efficacy of umbilical cord blood cells therapy in patients with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30486.

  517. BUCHANAN A, Sint K, Stefanovics E, Rosenheck R, et al
    An 18-month longitudinal study of suicidality in patients diagnosed with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30477.
    PubMed     Abstract available

  518. WORTHINGTON MA, Walker EF, Addington J, Bearden CE, et al
    Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30480.
    PubMed     Abstract available

    Commentary on "Lower speech connectedness linked to incidence of psychosis in people at clinical high risk": The promise of graph theory and network neuroscience.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30482.

  520. PARRISH EM, Depp CA, Moore RC, Harvey PD, et al
    Emotional determinants of life-space through GPS and ecological momentary assessment in schizophrenia: What gets people out of the house?
    Schizophr Res. 2020;224:67-73.
    PubMed     Abstract available

  521. FENG T, McEvoy JP, Miller BJ
    Longitudinal study of inflammatory markers and psychopathology in schizophrenia.
    Schizophr Res. 2020;224:58-66.
    PubMed     Abstract available

    September 2020
  522. TORII Y, Iritani S, Sekiguchi H, Habuchi C, et al
    The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30470.

  523. WEZENBERG BN, Hagen JM, Sutterland AL, Schrantee A, et al
    Association between Advanced Glycation End products and brain volumes in recent onset psychosis.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30468.

  524. PUJOL N, Mane A, Berge D, Mezquida G, et al
    Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30430.
    PubMed     Abstract available

  525. PARK YW, Choi D, Lee J, Ahn SS, et al
    Differentiating patients with schizophrenia from healthy controls by hippocampal subfields using radiomics.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30467.
    PubMed     Abstract available

  526. MORRENS M, De Picker L, Kampen JK, Coppens V, et al
    Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis.
    Schizophr Res. 2020 Sep 24. pii: S0920-9964(20)30465.
    PubMed     Abstract available

  527. MARKOVIC A, Buckley A, Driver DI, Dillard-Broadnax D, et al
    Sleep spindle activity in childhood onset schizophrenia: Diminished and associated with clinical symptoms.
    Schizophr Res. 2020 Sep 23. pii: S0920-9964(20)30450.
    PubMed     Abstract available

  528. FRIEDMAN-YAKOOBIAN MS, Parrish EM, Eack SM, Keshavan MS, et al
    Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial.
    Schizophr Res. 2020 Sep 22. pii: S0920-9964(20)30461.
    PubMed     Abstract available

  529. HUMPSTON C, Harrow M, Rosen C
    Behind the opaque curtain: A 20-year longitudinal study of dissociative and first-rank symptoms in schizophrenia-spectrum psychoses, other psychoses and non-psychotic disorders.
    Schizophr Res. 2020 Sep 19. pii: S0920-9964(20)30412.
    PubMed     Abstract available

  530. PRUETT BS, Meador-Woodruff JH
    Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Sep 18. pii: S0920-9964(20)30459.
    PubMed     Abstract available

  531. SPENCER TJ, Thompson B, Oliver D, Diederen K, et al
    Lower speech connectedness linked to incidence of psychosis in people at clinical high risk.
    Schizophr Res. 2020 Sep 17. pii: S0920-9964(20)30458.
    PubMed     Abstract available

  532. NAKAMURA R, Asami T, Yoshimi A, Kato D, et al
    Illness management and recovery program induced neuroprotective effects on language network in schizophrenia.
    Schizophr Res. 2020 Sep 16. pii: S0920-9964(20)30454.

  533. PETROVIC-VAN DER DEEN FS, Cunningham R, Manuel J, Gibb S, et al
    Exploring indigenous ethnic inequities in first episode psychosis in New Zealand - A national cohort study.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30460.
    PubMed     Abstract available

  534. KINNUNEN L, Nordstrom T, Niemela M, Rasanen S, et al
    Parental somatic illnesses and their association with prodromal symptoms of psychosis among offspring.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30448.

  535. DANEAULT JG, Shah JL
    Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30388.

  536. CALKINS ME, Woods SW, Bearden CE, Liu L, et al
    Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30442.
    PubMed     Abstract available

  537. GAMA MARQUES J, Bento A
    Homeless, nameless and helpless: John Doe syndrome in treatment resistant schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30455.

  538. BRIEND F, Nathou C, Delcroix N, Dollfus S, et al
    A new toolbox to compare target localizations for non-invasive brain stimulation: An application of rTMS treatment for auditory hallucinations in schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30457.
    PubMed     Abstract available

  539. HARVEY PD, Horan WP, Atkins AS, Stevens H, et al
    Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30438.
    PubMed     Abstract available

  540. SARAC C, Bilgrami ZR, Haas SS, Herrera SN, et al
    Processing speed and brain volume in individuals at clinical high-risk for psychosis with comorbid eating disorders: A brief report.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30453.

  541. BURRER A, Caravaggio F, Manoliu A, Plitman E, et al
    Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30446.
    PubMed     Abstract available

  542. FAAY MDM, van Baal GCM, Arango C, Diaz-Caneja CM, et al
    Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30449.
    PubMed     Abstract available

  543. REMPFER MV, McDowd JM, Brown CE
    Longitudinal stability of learning potential in people with schizophrenia: A 2.5 year follow-up.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30447.

  544. RAJALU BM, Jayarajan D, Muliyala KP, Sharma P, et al
    Self-reported tobacco use and urine cotinine levels in persons with schizophrenia.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30452.

    August 2020
  545. NEILL E, Tan EJ, Toh WL, Selvendra A, et al
    Examining which factors influence age of onset in males and females with schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30439.
    PubMed     Abstract available

  546. WUTHRICH F, Pavlidou A, Stegmayer K, Eisenhardt S, et al
    Nonverbal communication remains untouched: No beneficial effect of symptomatic improvement on poor gesture performance in schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30441.
    PubMed     Abstract available

  547. GLENTHOJ LB, Mariegaard LS, Fagerlund B, Jepsen JRM, et al
    Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.
    Schizophr Res. 2020 Aug 29. pii: S0920-9964(20)30444.
    PubMed     Abstract available

  548. SON S, Arai M, Miyata J, Toriumi K, et al
    Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia.
    Schizophr Res. 2020 Aug 22. pii: S0920-9964(20)30435.
    PubMed     Abstract available

  549. PERRY BI, Jones HJ, Richardson TG, Zammit S, et al
    Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort.
    Schizophr Res. 2020 Aug 19. pii: S0920-9964(20)30434.
    PubMed     Abstract available

  550. VAN ASSCHE L, Emsell L, Claes L, Van de Ven L, et al
    Hippocampal volume as a vulnerability marker for late onset psychosis: Associations with memory function and childhood trauma.
    Schizophr Res. 2020 Aug 17. pii: S0920-9964(20)30432.

  551. KODESH A, Goldberg Y, Rotstein A, Weinstein G, et al
    Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study.
    Schizophr Res. 2020 Aug 14. pii: S0920-9964(20)30413.
    PubMed     Abstract available

    Commentary on "Relationships between psychiatric symptoms, functioning and personal recovery in psychosis" by Best et al.
    Schizophr Res. 2020 Aug 10. pii: S0920-9964(20)30431.

  553. ERSHOVA ES, Malinovskaya EM, Golimbet VE, Lezheiko TV, et al
    Copy number variations of satellite III (1q12) and ribosomal repeats in health and schizophrenia.
    Schizophr Res. 2020 Aug 6. pii: S0920-9964(20)30415.
    PubMed     Abstract available

  554. HIDESE S, Ota M, Matsuo J, Ishida I, et al
    Association between obesity and white matter microstructure impairments in patients with schizophrenia: A whole-brain magnetic resonance imaging study.
    Schizophr Res. 2020 Aug 5. pii: S0920-9964(20)30395.
    PubMed     Abstract available

  555. DAVIS BJ, Lysaker PH, Salyers MP, Minor KS, et al
    The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30403.
    PubMed     Abstract available

  556. HWANG WJ, Cho KIK, Kwak YB, Lee J, et al
    Intact thalamic microstructure in asymptomatic relatives of schizophrenia patients with high genetic loading.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30394.
    PubMed     Abstract available

  557. LANGER AI, Schmidt C, Vergara R, Mayol-Troncoso R, et al
    Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30398.

    The DOSMD challenge and the COVID-19 conundrum.
    Schizophr Res. 2020;222:475-476.

  559. GROVER S, Mishra E, Chakrabarti S, Mehra A, et al
    Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic.
    Schizophr Res. 2020;222:489-490.

    July 2020
  560. BALZAN RP, Moritz S
    Cognitive biases and psychosis: From bench to bedside.
    Schizophr Res. 2020 Jul 30. pii: S0920-9964(20)30400.

  561. RAGLAND JD, Liu XL, Williams AB, Tully LM, et al
    Retrieval practice facilitation of family psychoeducation in people with early psychosis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30402.
    PubMed     Abstract available

  562. MISIAK B, Wisniewski M, Lis M, Samochowiec J, et al
    Glucose homeostasis in unaffected first-degree relatives of schizophrenia patients: A systematic review and meta-analysis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30397.
    PubMed     Abstract available

  563. O'HARE KJM, Korhonen T, Latvala A, Kaprio J, et al
    Association of subclinical psychosis with suicidal ideation: A twin study.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30396.
    PubMed     Abstract available

  564. AVERY SN, McHugo M, Armstrong K, Blackford JU, et al
    Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30393.
    PubMed     Abstract available

  565. YANG Y, Ning X, Wang X, Wang J, et al
    Triglyceride/glucose index is a reliable predictor of insulin resistance in schizophrenia.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30392.

  566. BANNAI D, Lutz O, Lizano P
    Neuroimaging considerations when investigating choroid plexus morphology in idiopathic psychosis.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30399.

  567. SYDNOR VJ, Roalf DR
    A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.
    Schizophr Res. 2020 Jul 25. pii: S0920-9964(20)30380.
    PubMed     Abstract available

  568. ALI SA, Moyett A, Argyelan M, Barber AD, et al
    The effects of lorazepam on cortico-striatal connectivity in schizophrenia.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30390.

  569. PETROS N, Cullen AE, Fusar-Poli P, Mechelli A, et al
    Towards standardising the assessment of good outcome in people at clinical high risk for psychosis: A collaborative approach.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30391.

  570. TORII Y, Iritani S, Marui T, Sekiguchi H, et al
    Morphological alteration of myelin-oligodendrocytes in a schizophrenic patient with 22q11.2 deletion syndrome: An autopsy study.
    Schizophr Res. 2020 Jul 22. pii: S0920-9964(20)30389.

  571. CUI H, Giuliano AJ, Zhang T, Xu L, et al
    Cognitive dysfunction in a psychotropic medication-naive, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Schizophr Res. 2020 Jul 18. pii: S0920-9964(20)30370.
    PubMed     Abstract available

  572. LINDENMAYER JP, Goldring A, Borne S, Khan A, et al
    Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia.
    Schizophr Res. 2020 Jul 17. pii: S0920-9964(20)30387.
    PubMed     Abstract available

  573. WANG Y, Wei Y, Edmiston EK, Womer FY, et al
    Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30298.
    PubMed     Abstract available

  574. JANSEN JE, Gleeson J, Bendall S, Rice S, et al
    Acceptance-and mindfulness-based interventions for persons with psychosis: Authors reply.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30374.

  575. GOTRA MY, Hill SK, Gershon ES, Tamminga CA, et al
    Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.
    Schizophr Res. 2020 Jul 13. pii: S0920-9964(20)30385.
    PubMed     Abstract available

  576. EACK SM, Keshavan MS
    Cognition, negative symptoms, and functional outcome in psychosis.
    Schizophr Res. 2020 Jul 6. pii: S0920-9964(20)30381.

  577. KARPINSKI P, Samochowiec J, Sasiadek MM, Laczmanski L, et al
    Analysis of global gene expression at seven brain regions of patients with schizophrenia.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30384.
    PubMed     Abstract available

  578. HABTEWOLD TD, Liemburg EJ, Islam MA, de Zwarte SMC, et al
    Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30272.
    PubMed     Abstract available

  579. CHAUMETTE B, Sengupta SM, Lepage M, Malla A, et al
    A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.
    Schizophr Res. 2020 Jul 2. pii: S0920-9964(20)30371.
    PubMed     Abstract available

    June 2020
  580. BEST MW, Law H, Pyle M, Morrison AP, et al
    Relationships between psychiatric symptoms, functioning and personal recovery in psychosis.
    Schizophr Res. 2020 Jun 30. pii: S0920-9964(20)30378.
    PubMed     Abstract available

  581. MATHESON GJ, Plaven-Sigray P, Louzolo A, Borg J, et al
    Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(20)30345.
    PubMed     Abstract available

  582. CHATURVEDI R, Kraus M, Keefe RSE
    A new measure of authentic auditory emotion recognition: Application to patients with schizophrenia.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(19)30550.
    PubMed     Abstract available

  583. BECHI M, Crespi SA, Agostoni G, Prudenziati F, et al
    The role of agency in schizophrenia: A pilot study on gaze agency.
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30377.

    Early intervention services for psychosis in the metaphorical 'trenches' of contemporary care: Already known from the real trenches of WW1?
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30373.

  585. GARCIA-MIERES H, Usall J, Feixas G, Ochoa S, et al
    Gender differences in the complexity of personal identity in psychosis.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30376.

  586. PURUSHOTHAMAN D, Jacob A, Kumar V, Varambally S, et al
    "To co-operate or not?" Risky co-operative behavior in Schizophrenia and the effect of vasopressin.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30365.
    PubMed     Abstract available

  587. CANAL-RIVERO M, Ruiz-Veguilla M, Labad J, Ayesa-Arriola R, et al
    Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis patients: A three-year follow-up study.
    Schizophr Res. 2020 Jun 26. pii: S0920-9964(20)30363.

  588. LEON-ORTIZ P, Reyes-Madrigal F, Kochunov P, Gomez-Cruz G, et al
    White matter alterations and the conversion to psychosis: A combined diffusion tensor imaging and glutamate (1)H MRS study.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30358.
    PubMed     Abstract available

  589. LARSEN KM, Dzafic I, Darke H, Pertile H, et al
    Aberrant connectivity in auditory precision encoding in schizophrenia spectrum disorder and across the continuum of psychotic-like experiences.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30341.
    PubMed     Abstract available

  590. KAFADAR E, Mittal VA, Strauss GP, Chapman HC, et al
    Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30224.
    PubMed     Abstract available

  591. LASALVIA A, Vita A, Bellomo A, Tusconi M, et al
    Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30157.
    PubMed     Abstract available

  592. WOOD L, Williams C, Billings J, Johnson S, et al
    A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30152.
    PubMed     Abstract available

  593. CHAVES CB, Vieira-Coelho MA
    Clinical trials with monoclonal antibodies in schizophrenia.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30278.

  594. OLIVER D, Spada G, Colling C, Broadbent M, et al
    Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis.
    Schizophr Res. 2020 Jun 19. pii: S0920-9964(20)30259.
    PubMed     Abstract available

  595. POLETTI M, Raballo A
    Disembodiment and schizophrenia: Looking at the motor roots of minimal self disorders in a developmental perspective.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30359.

    Ketamine, NMDA hypofunction, and sleep oscillatory abnormalities in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30361.

  597. SABOUR S
    Clozapine screening in people taking clozapine: Understanding diagnostic accuracy in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30364.

  598. MAGUIRE J, Sizer H, Mifsud N, O'Donoghue B, et al
    Outcomes for migrants with a first episode of psychosis: A systematic review.
    Schizophr Res. 2020 Jun 16. pii: S0920-9964(20)30302.
    PubMed     Abstract available

  599. DONDE C, Achim AM, Brunelin J, Poulet E, et al
    A meta-analysis of craving studies in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Jun 15. pii: S0920-9964(20)30300.
    PubMed     Abstract available

  600. KOCH E, Rosenthal B, Lundquist A, Chen CH, et al
    Interactome overlap between schizophrenia and cognition.
    Schizophr Res. 2020 Jun 13. pii: S0920-9964(20)30346.
    PubMed     Abstract available

  601. SONI S, Muthukrishnan SP, Sood M, Kaur S, et al
    Altered parahippocampal gyrus activation and its connectivity with resting-state network areas in schizophrenia: An EEG study.
    Schizophr Res. 2020 Jun 10. pii: S0920-9964(20)30177.
    PubMed     Abstract available

  602. HASSON-OHAYON I, Scholte-Stalenhoef AN, Schirmbeck F, de Haan L, et al
    Insight, personality, and symptoms among individuals with psychosis: Cross-sectional and longitudinal relationships.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30296.
    PubMed     Abstract available

  603. SANTESTEBAN-ECHARRI O, Haffey P, Kim G, Tang J, et al
    A mobile-based app to monitor cannabis use among youth at clinical high risk (CHR) for psychosis: Feasibility and acceptability of LooseLeaf.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30285.

  604. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2020 Jun 7. pii: S0920-9964(20)30226.
    PubMed     Abstract available

  605. GARCIA-MIERES H, De Jesus-Romero R, Ochoa S, Feixas G, et al
    Beyond the cognitive insight paradox: Self-reflectivity moderates the relationship between depressive symptoms and general psychological distress in psychosis.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30279.
    PubMed     Abstract available

  606. CASTELNOVO A, Aquilino D, Parabiaghi A, D'Agostino A, et al
    Could CBT sustain long-term remission without antipsychotic medication in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30340.

  607. SADH K, Mehta UM, Muralidharan K, Shankar NS, et al
    Understanding the role of language in patients with psychosis and hearing impairment, experiencing auditory verbal hallucinations.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30343.

  608. UZER-KREMERS L, Bralet MC, Angerville B, Jeanblanc J, et al
    Is self-compassion linked to treatment adherence in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30338.

  609. SUHAS S, Kumar V, Damodharan D, Sharma P, et al
    Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30337.
    PubMed     Abstract available

  610. VAN DER VEN E, Scodes J, Basaraba C, Pauselli L, et al
    Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York state.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30331.
    PubMed     Abstract available

  611. BOLDRINI T, Pontillo M, Tanzilli A, Giovanardi G, et al
    An attachment perspective on the risk for psychosis: Clinical correlates and the predictive value of attachment patterns and mentalization.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30332.
    PubMed     Abstract available

  612. GROVER S, Shouan A, Chakrabarti S, Sahoo S, et al
    Effectiveness of ECT in Management of Depression in patients with schizophrenia: An Open Labelled Study.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30254.

  613. ZEPPILLO T, Schulmann A, Macciardi F, Hjelm BE, et al
    Functional impairment of cortical AMPA receptors in schizophrenia.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30147.
    PubMed     Abstract available

  614. MORITZ S, Scheunemann J, Ludtke T, Westermann S, et al
    Prolonged rather than hasty decision-making in schizophrenia using the box task. Must we rethink the jumping to conclusions account of paranoia?
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30336.
    PubMed     Abstract available

  615. KUBOTA M, Moriguchi S, Takahata K, Nakajima S, et al
    Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30180.
    PubMed     Abstract available

  616. BASAVARAJU R, Ithal D, Ramalingaiah AH, Thirthalli J, et al
    "Apathetic to hypomanic/manic": A case series-illustration of emergent mood symptoms during intermittent theta burst stimulation (iTBS) of cerebellar vermis in schizophrenia with predominant negative symptoms.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30291.

  617. DEAN B, Pavey G, Scarr E
    Higher levels of alpha7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30288.
    PubMed     Abstract available

  618. CHANG CK, Chen PH, Pan CH, Su SS, et al
    Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30265.
    PubMed     Abstract available

  619. BARTH C, Jorgensen KN, Wortinger LA, Nerland S, et al
    Trajectories of brain volume change over 13 years in chronic schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30266.

  620. HERNANDEZ-GARCIA M, Martin-Gomez C, Gomez-Garcia M, Gomez-Pilar J, et al
    Abnormal self-experiences related to a hypersynchronic brain state in schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30167.

  621. LUTZ O, Lizano P, Mothi SS, Zeng V, et al
    Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30087.
    PubMed     Abstract available

  622. ZAHEER J, Olfson M, Mallia E, Lam JSH, et al
    Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30232.
    PubMed     Abstract available

  623. SCHNELL T, Moritz S
    Less self-stigmatization and more empowerment in patients with schizophrenia and comorbid cannabis use disorder compared to non-comorbid schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30268.

  624. COUSTALS N, Martelli C, Brunet-Lecomte M, Petillion A, et al
    Chronic smoking and cognition in patients with schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30182.
    PubMed     Abstract available

  625. XI C, Liu ZN, Yang J, Zhang W, et al
    Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30252.
    PubMed     Abstract available

    Letter to the editor re: "Delay discounting abnormalities are seen in first-episode schizophrenia but not in bipolar disorder" by Wang et al.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30215.

  627. KELLEHER E, McNamara P, Dunne J, Fitzmaurice B, et al
    Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(19)30530.
    PubMed     Abstract available

  628. CORCORAN CM, Mittal VA, Bearden CE, E Gur R, et al
    Language as a biomarker for psychosis: A natural language processing approach.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(20)30247.
    PubMed     Abstract available

  629. IFTENI P, Dima L, Teodorescu A
    Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge.
    Schizophr Res. 2020;220:265-266.

    May 2020
  630. CHWA WJ, Tishler TA, Raymond C, Tran C, et al
    Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.
    Schizophr Res. 2020 May 31. pii: S0920-9964(20)30207.
    PubMed     Abstract available

  631. WOODWARD ML, Lin J, Gicas KM, Su W, et al
    Medial temporal lobe cortical changes in response to exercise interventions in people with early psychosis: A randomized controlled trial.
    Schizophr Res. 2020 May 30. pii: S0920-9964(20)30297.
    PubMed     Abstract available

  632. MEISEBERG J, Moritz S
    Biases in diagnostic terminology: Clinicians choose different symptom labels depending on whether the same case is framed as depression or schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30161.
    PubMed     Abstract available

  633. OH SJ, Fan X
    Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30304.

  634. MARINO L, Scodes J, Richkin T, Alves-Bradford JM, et al
    Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30289.
    PubMed     Abstract available

  635. LIU J, Lim MSM, Ng BT, Chong SA, et al
    Global emotion dysregulation and maladaptive cognitive emotion regulation strategies mediate the effects of severe trauma on depressive and positive symptoms in early non-affective psychosis.
    Schizophr Res. 2020 May 27. pii: S0920-9964(20)30294.
    PubMed     Abstract available

  636. ALMULLA AF, Al-Hakeim HK, Abed MS, Carvalho AF, et al
    Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30255.
    PubMed     Abstract available

  637. RADUA J, Davies C, Fusar-Poli P
    Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30262.
    PubMed     Abstract available

  638. NICHOLS J, Gannon JM, Conlogue J, Sarpal D, et al
    Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30333.

    Sleep disturbances in schizophrenia and psychosis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30274.

  640. WANG X, Lu F, Duan X, Han S, et al
    Frontal white matter abnormalities reveal the pathological basis underlying negative symptoms in antipsychotic-naive, first-episode patients with adolescent-onset schizophrenia: Evidence from multimodal brain imaging.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30293.
    PubMed     Abstract available

  641. COSTANTINI M, Salone A, Martinotti G, Fiori F, et al
    Body representations and basic symptoms in schizophrenia.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30292.
    PubMed     Abstract available

  642. MONGAN D, Sabherwal S, Susai SR, Focking M, et al
    Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30290.
    PubMed     Abstract available

  643. LANG X, Wang DM, Du XD, Jia QF, et al
    Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms.
    Schizophr Res. 2020 May 22. pii: S0920-9964(20)30286.
    PubMed     Abstract available

  644. TAKAHASHI T, Tsugawa S, Nakajima S, Plitman E, et al
    Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30223.
    PubMed     Abstract available

  645. SCORIELS L, Genaro LT, Mororo LGC, Keffer S, et al
    Auditory versus visual neuroscience-informed cognitive training in schizophrenia: Effects on cognition, symptoms and quality of life.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30269.
    PubMed     Abstract available

  646. BAYTUNCA BM, Kalyoncu T, Ozbaran B, Kose S, et al
    Reduced blood agmatine level in early-onset schizophrenia.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30258.

  647. KLINE ER
    Commentary: Expressed emotion as a mechanistic target in psychosis early intervention.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30263.

  648. GRAY R, Shrestha M, Brown E
    Acceptance- and mindfulness-based interventions for persons with psychosis: Potential errors in reported meta-analyses.
    Schizophr Res. 2020 May 19. pii: S0920-9964(20)30273.

  649. LEI G, Liu F, Liu P, Jiao T, et al
    Does genetic mouse model of constitutive Hint1 deficiency exhibit schizophrenia-like behaviors?
    Schizophr Res. 2020 May 18. pii: S0920-9964(20)30270.
    PubMed     Abstract available

  650. DEAN DJ, Woodward N, Walther S, McHugo M, et al
    Cognitive motor impairments and brain structure in schizophrenia spectrum disorder patients with a history of catatonia.
    Schizophr Res. 2020 May 15. pii: S0920-9964(20)30264.
    PubMed     Abstract available

  651. WANG SP, Wang JD, Chang JH, Wu BJ, et al
    Frailty affects employment outcomes in patients with schizophrenia in noncompetitive employment: A 4-year longitudinal study.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30233.
    PubMed     Abstract available

  652. FORMICA MJC, Phillips LJ, Hartmann JA, Yung AR, et al
    Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30235.
    PubMed     Abstract available

  653. WOODS SW, Bearden CE, Sabb FW, Stone WS, et al
    Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30227.
    PubMed     Abstract available

  654. KUMARI V, Ettinger U
    Controlled sleep deprivation as an experimental medicine model of schizophrenia: An update.
    Schizophr Res. 2020 May 8. pii: S0920-9964(20)30175.
    PubMed     Abstract available

  655. PILLNY M, Schlier B, Lincoln TM
    "I just don't look forward to anything". How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30170.
    PubMed     Abstract available

  656. MONTAGNESE M, Knolle F, Haarsma J, Griffin JD, et al
    Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30229.
    PubMed     Abstract available

  657. BROWN E, Gray R, Lo Monaco S, O'Donoghue B, et al
    The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research.
    Schizophr Res. 2020 May 6. pii: S0920-9964(20)30257.
    PubMed     Abstract available

  658. FRAJMAN A, Maggio N, Muler I, Haroutunian V, et al
    Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia.
    Schizophr Res. 2020 May 3. pii: S0920-9964(20)30234.
    PubMed     Abstract available

    April 2020
  659. DEVOE DJ, Lu L, Cannon TD, Cadenhead KS, et al
    Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
    Schizophr Res. 2020 Apr 30. pii: S0920-9964(20)30211.
    PubMed     Abstract available

  660. YEE N, Matheson S, Korobanova D, Large M, et al
    A meta-analysis of the relationship between psychosis and any type of criminal offending, in both men and women.
    Schizophr Res. 2020 Apr 29. pii: S0920-9964(20)30216.
    PubMed     Abstract available

  661. FROHLICH F, Lustenberger C
    Neuromodulation of sleep rhythms in schizophrenia: Towards the rational design of non-invasive brain stimulation.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30210.
    PubMed     Abstract available

  662. VIOLEAU L, Valery KM, Fournier T, Prouteau A, et al
    How continuum beliefs can reduce stigma of schizophrenia: The role of perceived similarities.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30221.
    PubMed     Abstract available

  663. OLIVER D, Spada G, Englund A, Chesney E, et al
    Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study.
    Schizophr Res. 2020 Apr 24. pii: S0920-9964(20)30222.
    PubMed     Abstract available

  664. YOLKEN R, Prandovszky E, Severance EG, Hatfield G, et al
    The oropharyngeal microbiome is altered in individuals with schizophrenia and mania.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30113.
    PubMed     Abstract available

  665. KELLY JR, Minuto C, Cryan JF, Clarke G, et al
    The role of the gut microbiome in the development of schizophrenia.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30086.
    PubMed     Abstract available

  666. SUBOTNIK KL, Ventura J, Hellemann GS, Zito MF, et al
    Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Apr 22. pii: S0920-9964(20)30148.
    PubMed     Abstract available

  667. VALIENTE-PALLEJA A, Torrell H, Alonso Y, Vilella E, et al
    Increased blood lactate levels during exercise and mitochondrial DNA alterations converge on mitochondrial dysfunction in schizophrenia.
    Schizophr Res. 2020 Apr 21. pii: S0920-9964(20)30181.
    PubMed     Abstract available

  668. LUCKHOFF H, Asmal L, Kilian S, Scheffler F, et al
    Sex versus gender as risk factors for the age of onset of schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 20. pii: S0920-9964(20)30219.

  669. WATERS F, Chiu VW, Dragovic M, Ree M, et al
    Different patterns of treatment response to Cognitive-Behavioural Therapy for Insomnia (CBT-I) in psychosis.
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30165.
    PubMed     Abstract available

  670. KURTULMUS A, Elbay A, Ozdemir MH
    Response to commentary "Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients".
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30208.

  671. SHEFFIELD JM, Rogers BP, Blackford JU, Heckers S, et al
    Insula functional connectivity in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30179.
    PubMed     Abstract available

  672. FERNANDEZ-SOTOS P, Garcia-Martinez B, Ricarte JJ, Latorre JM, et al
    Electroencephalographic spectral analysis from a wireless low-cost brain-computer interface for symptom capture of auditory verbal hallucinations in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30218.

  673. RABALLO A, Poletti M, Preti A, McGorry P, et al
    Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30174.
    PubMed     Abstract available

  674. BARRY AB, Koeppel JA, Ho BC
    Impulsive decision making, brain cortical thickness and familial schizophrenia risk.
    Schizophr Res. 2020 Apr 15. pii: S0920-9964(20)30206.
    PubMed     Abstract available

  675. VERNAL DL, Boldsen SK, Lauritsen MB, Correll CU, et al
    Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study.
    Schizophr Res. 2020 Apr 13. pii: S0920-9964(20)30155.
    PubMed     Abstract available

  676. VIHER PV, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Altered diffusion in motor white matter tracts in psychosis patients with catatonia.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30120.
    PubMed     Abstract available

  677. MINICHINO A, Brondino N, Solmi M, Del Giovane C, et al
    The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30101.
    PubMed     Abstract available

  678. QIAN N, Lipkin RM, Kaszowska A, Silipo G, et al
    Computational modeling of excitatory/inhibitory balance impairments in schizophrenia.
    Schizophr Res. 2020 Apr 11. pii: S0920-9964(20)30133.
    PubMed     Abstract available

  679. PAQUIN V, Lemire M, King S
    Ecosystem approaches to the risk for schizophrenia.
    Schizophr Res. 2020 Apr 10. pii: S0920-9964(20)30168.

  680. CHAN SKW, Chan HYV, Pang HH, Hui CLM, et al
    Ten-year trajectory and outcomes of negative symptoms of patients with first-episode schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 8. pii: S0920-9964(20)30172.
    PubMed     Abstract available

  681. PARDO-DE-SANTAYANA G, Vazquez-Bourgon J, Gomez-Revuelta M, Ayesa-Arriola R, et al
    Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study.
    Schizophr Res. 2020 Apr 7. pii: S0920-9964(20)30112.
    PubMed     Abstract available

  682. NAKONEZNY PA, Lindow JC, Stroup TS, McEvoy JP, et al
    A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30164.
    PubMed     Abstract available

  683. YANG LH, Ruiz B, Mandavia AD, Grivel MM, et al
    Advancing study of cognitive impairments for antipsychotic-naive psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30060.
    PubMed     Abstract available

  684. LI XB, Jiang WL, Wen YJ, Wang CM, et al
    The attenuated visual scanpaths of patients with schizophrenia whilst recognizing emotional facial expressions are worsened in natural social scenes.
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30150.
    PubMed     Abstract available

  685. COWAN HR
    Is schizophrenia research relevant during the COVID-19 pandemic?
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30209.
    PubMed     Abstract available

  686. JALLES C, Chendo I, Levy P, Reimao S, et al
    Neuromelanin changes in first episode psychosis with substance abuse.
    Schizophr Res. 2020 Apr 3. pii: S0920-9964(20)30140.

    Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30171.

  688. PELIZZA L, Poletti M, Azzali S, Paterlini F, et al
    Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30163.
    PubMed     Abstract available

  689. BANNAI D, Lizano P
    Identifying retinal layer endophenotypes for schizophrenia.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30166.

  690. XAVIER G, Santoro ML, Ota VK, Spindola LM, et al
    Blood gene expression changes after Risperidone treatment in an antipsychotic-naive cohort of first episode of psychosis patients.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30139.

  691. TOROUS J, Keshavan M
    COVID-19, mobile health and serious mental illness.
    Schizophr Res. 2020;218:36-37.

    March 2020
  692. KIM SJ, Jung DU, Moon JJ, Jeon DW, et al
    Effects of an extrinsic motivator on the evaluation of cognitive and daily living functions in patients with schizophrenia.
    Schizophr Res. 2020 Mar 30. pii: S0920-9964(20)30142.
    PubMed     Abstract available

  693. EGER G, Reuven Y, Dreiher J, Shvartzman P, et al
    Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study.
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30149.
    PubMed     Abstract available

  694. ACOSTA FJ, Navarro S, Cabrera B, Ramallo-Farina Y, et al
    Painful insight vs. usable insight in schizophrenia. Do they have different influences on suicidal behavior?
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30151.
    PubMed     Abstract available

  695. UMEH A, Kumar J, Francis ST, Liddle PF, et al
    Global fMRI signal at rest relates to symptom severity in schizophrenia.
    Schizophr Res. 2020 Mar 25. pii: S0920-9964(20)30141.

  696. EMSLEY R
    Guest editorial: Special issue on maintenance treatment in schizophrenia.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30135.

  697. CASTELNOVO A, Zago M, Casetta C, Zangani C, et al
    Slow wave oscillations in Schizophrenia First-Degree Relatives: A confirmatory analysis and feasibility study on slow wave traveling.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30131.
    PubMed     Abstract available

  698. LIANG S, Deng W, Li X, Wang Q, et al
    Aberrant posterior cingulate connectivity classify first-episode schizophrenia from controls: A machine learning study.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30128.
    PubMed     Abstract available

  699. BREBION G, Stephan-Otto C, Cuevas-Esteban J, Usall J, et al
    Impaired memory for temporal context in schizophrenia patients with hallucinations and thought disorganisation.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30116.
    PubMed     Abstract available

  700. RANGASWAMY T, Cohen A
    Invited commentary from a LAMIC country: Thirty-five years of schizophrenia - the Madras Longitudinal study.
    Schizophr Res. 2020 Mar 23. pii: S0920-9964(20)30132.

    January 2020
  701. VELLIGAN DI, Maples NJ, Pokorny JJ, Wright C, et al
    Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Schizophr Res. 2020;215:17-24.
    PubMed     Abstract available

  702. BLESS JJ, Hjelmervik H, Torsheim T, Gudmundsen M, et al
    Temporal signatures of auditory verbal hallucinations: An app-based experience sampling study.
    Schizophr Res. 2020;215:442-444.

  703. SPOOV J, Bredbacka PE, Stenman UH
    Separation of positive and disorganization symptoms by prolactin response to 12.5 mug intravenous TRH.
    Schizophr Res. 2020;215:449-450.

  704. VOSTRIKOV VM, Uranova NA
    Reduced density of oligodendrocytes and oligodendrocyte clusters in the caudate nucleus in major psychiatric illnesses.
    Schizophr Res. 2020;215:211-216.
    PubMed     Abstract available

  705. HAJDUK M, Achim AM, Brunet-Gouet E, Mehta UM, et al
    How to move forward in social cognition research? Put it into an international perspective.
    Schizophr Res. 2020;215:463-464.

  706. HARVEY PD, Saoud JB, Luthringer R, Moroz S, et al
    Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression.
    Schizophr Res. 2020;215:352-356.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.